The role of ORF3 Protein in the Molecular Pathogenesis of Porcine circovirus 2 infection by ANBU KUMAR KARUPPANNAN
  
 
THE ROLE OF ORF3 PROTEIN  
IN THE MOLECULAR PATHOGENESIS OF  

































THE ROLE OF ORF3 PROTEIN  
IN THE MOLECULAR PATHOGENESIS OF  










ANBU KUMAR KARUPPANNAN 
(B.V.Sc., Madras Veterinary College, India,  












A THESIS SUBMITTED 





TEMASEK LIFE SCIENCES LABORATORY 
 










I am most thankful to my supervisor Professor Jimmy Kwang for 
providing me the precious opportunity to work in his lab, his valuable guidance 
and support throughout my stay in his laboratory. His wide knowledge, experience 
and interesting ideas have always amazed, educated and motivated me. His 
constant encouragement has always made me confident and has been a guiding 
beacon towards the goals of my work. 
I would like to thank my thesis committee, Dr. Vincent Chow, Dr. Cai Yu 
and Dr Toshiro Ito for their valuable comments and suggestions. Their diverse 
backgrounds and guidance has led my work in the proper direction. I also express 
my sincere thanks to all the past and current members of the Animal health 
biotechnology lab, especially, Dr. Liu Jue, Jennifer Lau, Zhu Yu, Jia Qiang, Dr. 
He Fang, Sumathy, Dr. Beau Fenner, Meng Tao, Dr. Syed Musthaq, TLL animal 
facility, TLL microscopy unit for their help, technical inputs and support in 
various aspects. All of them were always there when I needed help and support. I 
would like to express my appreciation to Song Yu, Kian Hong, Peck Junwei, and 
Reetu for stimulating scientific discussions and friendship. I also thank my family, 
especially my wife, for enduring me during the course of my study.  
Above all, I thank the Temasek Life Sciences Laboratory and National 
University of Singapore for providing me the opportunity and privilege of this 





TABLE OF CONTENTS 
TITLE…………………………………………………………………………….. i 
ACKNOWLEDGEMENTS……………………………………………………... ii 
TABLE OF CONTENTS………………………………………………………... iii 
SUMMARY………………………………………………………………………. vii 
LIST OF TABLES……………………………………………………………….. ix 
LIST OF FIGURES……………………………………………………………… x 
LIST OF SYMBOLS AND ABBREVIATIONS………………………………. xii 
LIST OF PUBLICATIONS……………………………………………………... xiv 
 
1 Chapter1: INTRODUCTION……………………………...……………... 1 
 1.1 Introduction…………………………………………………………. 2 
 1.2 PCV2 associated disease conditions (PCVAD) …………………… 2 
 1.3    Morphology and Replication cycle………………………………… 5 
 1.4    Transcriptome and proteome of PCV……………………………… 10 
 1.5    Morphogenesis ……………………………………………………. 14 
 1.6    Epidemiological history of porcine circovirus infections………….. 15 
 1.7    Evolutionary aspects of circoviruses……………………………….. 16 
 1.8    Transmission of the virus…………………………………………… 18 
 1.9    Model of the PCVAD development………………………………… 18 
 1.10 Host Virus interaction………………………………………………. 20 
 1.11 Thesis outline……………………………………………………….. 24 
2 Chapter 2: Ablation of ORF3 expression from porcine circovirus 2 
leads to the attenuation of its pathogenicity in SPF piglets …………… 26 
 2.1 Introduction………………………………………………………….. 27 




2.2.1 Viruses and cell culture……………………………………… 29 
 
 
2.2.2 Generation of Mutant viruses and their characterization.…… 29 
 
 
2.2.3 Yeast two hybrid assays…………………………………….. 30 
 
 
2.2.4 Antibodies and recombinant proteins………………………. 30 
 
 
2.2.5 Experimental design………………………………………… 30 
 
 
2.2.6 Serological analysis…………………………………………. 32 
 
 
2.2.7 Quantitative real time PCR…………………………………. 32 
 
 
2.2.8 Histology…………………………………………………….. 33 
 
 
2.2.9 Flow cytometry……………………………………………… 34 
 2.3 Results……………………………………………………………….. 35 
 
 
2.3.1 Mutations and genetic stability of the virus.………………… 35 
 
 
2.3.2 Molecular interaction between ORF3 and Pirh2…………….. 39 
 
 
2.3.3 Characterization of the double mutant virus in vivo………… 43 
 
 
2.3.4 Serum viremia and virus specific antibody response……….. 43 
 
 
2.3.5 Lymphocyte counts………………………………………….. 48 
 
 
2.3.6 Histological findings………………………………………… 50 
 2.4 Discussion……………………………………………………………  
54 
3 Chapter 3: Porcine circovirus type 2 ORF3 protein competes with P53 
in binding to Pirh2 and mediates the deregulation of P53 homeostasis… 60 
 
3.1 Introduction………………………………………………………….. 61 
 
3.2 Materials and methods……………………………………………….. 65 
 
 
3.2.1 Cell culture and transient transfections………………………. 65 
 
 
3.2.2 Plasmids and recombinant proteins…………………………… 65 
 
 
3.2.3 Binding assays……………………………………………….. 66 
 
 




3.2.5 Immunofluorescence assays…………………………………. 68 
 
 
3.2.6 Estimation of protein turnover rates………………………….. 68 
 
 
3.2.7 MTT assay for cell viability………………………………….. 69 
 
 
3.2.8 Flowcytometry……………………………………………….. 69 
 
 
3.2.9 In vitro ubiquitination assay………………………………….. 70 
 3.3 Results………………………………………………………………… 71 
  
3.3.1 The ORF3 protein prevents p53 from binding pPirh2 in vitro 
and in vivo……………………………………………………  71 
  
3.3.2 ORF3 protein alters the subcellular localization of pPirh2…. 76 
  
3.3.3 Mapping of the minimal domain of ORF3 protein that binds 
with pPirh2…………………………………………………... 80 
  
3.3.4 Interaction of ORF3 protein with pPirh2 up-regulates cellular 
p53 levels…………………………………………………….. 86 
  
3.3.5 ORF3 interferes with the in vitro ubiquitination of p53…….. 88 
 
3.4 Discussion……………………………………………………………. 90 
4 Chapter 4: ORF3 of porcine circovirus 2 enhances the in vitro and in 
vivo spread of the virus.................……………………………………….... 94 
 
4.1 Introduction………………………………………………………….. 95 
 
4.2 Materials and methods……………………………………………….. 98 
 
 
4.2.1 Cell culture and viruses………………………………………. 98 
 
 
4.2.2 Quantitative real-time PCR………………………………….. 99 
 
 
4.2.3 Plasmids and transfection……………………………………. 99 
 
 
4.2.4 Western blot analysis………………………………………… 99 
 
 
4.2.5 Assay for caspase activity……………………………………. 100 
 
 
4.2.6 Mice infections studies………………………………………. 100 
 
4.3 Results……………………………………………………………….. 103 
 
 
4.3.1 Growth kinetics of wild-type PCV2 and ORF3-deficient 
PCV2.. ……………………………………………………..… 103 
 
 
4.3.2 Role of ORF3-induced apoptosis in the spread of the virus in 




4.3.3 Mixed culture of ORF3-deficient PCV2 with a chimeric 
PCV1-2 virus………………………………………………… 109 
 
 








4.4 Discussion…………………………………………………………….. 118 
5 Conclusion…………………………………………………………………… 123 
 
5.1 The role of ORF3 in the pathogenicity of PCV2 infection and the 
molecular mechanism behind the cellular pathogenesis……………... 124 
 
5.2 Future directions……………………………………………………… 129 
REFERENCES…………………………………………………………………. 131 
 



















Porcine circovirus 2 (PCV2) of the Circoviridae family is a nonenveloped, 
single stranded DNA virus with a circular genome of 1.7 kilobases. It is a major 
pathogen of porcine species causing growth retardation, lymphadenopathy, multi-
organ inflammation and immune suppression, especially affecting weanling 
piglets. The PCV2 open reading frame 3 (ORF3) codes a 104 amino acid protein 
that causes apoptosis of PCV2 infected cells, and is not essential for virus 
replication. This thesis describes the characterisation of the role of ORF3 in the 
molecular and the systemic pathogenesis during the PCV2 infection in cell 
culture, mice model and in natural infection in piglets.  
Mutant PCV2 lacking the expression of ORF3 are infectious and replicate 
in cells in vitro, but do not cause apoptosis of the infected cells. The ORF3 of 
PCV2 has been shown to be involved in the pathogenesis of the virus in mice 
model. In PCV2 infected piglets, B and CD4 T lymphocyte depletion and 
lymphoid organ destruction are generally observed; however, the ORF3 deficient 
PCV2 is attenuated in its pathogenicity in infected piglets. The mutant virus does 
not cause any observable disease or perturbation of the lymphocyte count in the 
inoculated piglets and elicits an efficient immune response. When compared with 
the wildtype virus infection, the ORF3 mutant PCV2 infection is characterized by 
mild viremia and absence of pathological lesions.  
In infected cells, the ORF3 protein interacts with the porcine homologue of 
Pirh2 (pPirh2), a p53-induced ubiquitin-protein E3 ligase and causes the 
accumulation of p53 by disrupting the physiological association of p53 and 
pPirh2. The ORF3 protein competes with p53 in binding to pPirh2. The amino 
 viii 
acid residues 20 to 65 of the ORF3 protein are essential in this interaction of 
ORF3 protein with pPirh2, which leads to an alteration in the cellular localization 
and a significant reduction in the stability of pPirh2. These events contribute to the 
deregulation of p53 by pPirh2, leading to increased p53 levels and apoptosis of the 
infected cells.  
In addition to its role in causing the apoptosis of the immune cells, 
characteristic of the PCV2 infection associated disease conditions, the ORF3 also 
plays a role in the systemic dissemination of the PCV2 infection. The ORF3 
expedites the spread of the virus by inducing the early release of the virus from 
the infected cells. Further, in PCV2 infected mice, the ORF3 induced apoptosis 
also aids in recruiting macrophages to phagocytise the infected apoptotic cells 
leading to the systemic dissemination of the infection. The apoptotic activity of 
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1. 1 Introduction  
The Porcine circovirus belong to the Circoviridae family which consists of 
small non enveloped DNA viruses with a single stranded circular DNA genome 
ranging from 1.7 kilobases to 3.6 kilobases (http://expasy.org/viralzone.html). The 
Circoviridae consists of viruses infecting both mammalian and avian species, e.g. 
Porcine circovirus, Bovine circovirus, Beak and feather disease virus, Pigeon 
circovirus, Goose circovirus, Canary circovirus, Starling circovirus, Finch 
circovirus, e.t.c. (Firth et al., 2009). To date there are two reported circoviruses 
that can infect porcine species, namely, the Porcine circovirus 1 (PCV1) and 
Porcine circovirus 2 (PCV2). The non-pathogenic PCV1 was initially identified as 
a surreptitious contaminant in the porcine kidney epithelial cell line called PK-15 
and the PCV1 does not induce any cytopathy and has been documented to be a 
non-evident infection in long-term serial passages of PK-15 cells (Allan et al., 
1995; Tischer et al., 1982, 1986). The insidious nature of PCV1 is reiterated by 
the recently reported contamination of PCV1 in cell lines used for human vaccine 
preparation (Victoria et al., 2010). The pathogenic PCV2, however, was identified 
much later, in 1997, to be associated with “Post weaning multisystemic wasting 
syndrome” (PMWS) in weanling piglets (Nayar et al., 1997). The PCV2 virus, 
unlike the PCV1 virus, causes apoptosis of the infected cells (Liu et al, 2005). 
Both the PCV1 and PCV2 are present ubiquitously in domesticated and wild 
porcine species throughout the globe. 
1.2 PCV2 associated disease conditions (PCVAD) 
The PCV2 infection and the resulting disease conditions primarily affect 
weanling piglets at 3 to 15 weeks age and has a high morbidity rate of up to 60% 
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(Segales and Domingo, 2002). In the affected farms, the mortality ranges from 
15% to 20% and occasionally reaches up to 80%. Pigs of all ages are succeptible 
to PCV2 infection, however weanling piglets are the most affected group. The 
PMWS is characterized by progressive weight loss, dyspnoea, generalized 
lymphadenopathy, lymphoid depletion, altered cytokine profile and reduced 
cytokine production in affected pigs (Darwich et al., 2002, 2004; Nielsen et al., 
2003; Segales et al., 2004; Shibahara et al., 2000). Histological lesions typically 
observed in the PMWS include  multinucleated giant cell formation in lymph 
nodes, and destruction of lymphoid organ architecture, with inflammatory lesions 
in multiple organs involving liver, kidney, lungs, which show lesions of 
histiocytic infiltration (Allan et al., 2004). Other conditions like porcine dermatitis 
and nephropathy syndrome (PDNS), pneumonia, necrotizing tracheitis, congenital 
tremors and fetal myocarditis have been associated with PCV2 infections 
(Darwich et al., 2004). The various conditions described to be associated with the 
PCV2 infection, are collectively known as porcine circovirus associated diseases 
(PCVAD) (Gillespie et al., 2009). The PCVADs cause a huge economic loss to 
the porcine production industry (Ramamoorthy et al., 2009) 
Pathogenesis of PCVAD is characterized by lymphopenia with a 
downshift of CD4 helper T lymphocytes, CD8 cytotoxic T lymphocytes, CD4 and 
CD8 double positive lymphocytes and IgM positive B-lymphocytes. These are 
believed to be indicative of an impaired immune system in the infected piglets 
(Darwich et al., 2002, 2004; Nielsen et al., 2003; Segales et al., 2004). The 
development of the PMWS is thought to be positively correlated with the 
proliferation of the lymphocytes induced by vaccination or co-infection with other 
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infectious agents in the experimental disease models of PMWS (Krakowka et al., 
2001, 2007; Ladekjaer-Mikkelsen et al., 2002). This enables the virus to replicate 
in the lymphoid cells and lead to the destruction of lymphoid cells. The impaired 
immune system and concurrent co-infection with other pathogens like Porcine 
reproductive and respiratory syndrome virus (PRRSV), Porcine parvovirus (PPV), 
Mycoplasma hyopneumoniae, etc, is common in PMWS affected pigs (Dorr et al., 





Figure 1. Co-infections of PCV2. Combinations of pathogens detected in 484 cases of 








1.3 Morphology and Replication cycle 
 
Figure 2. Electron micrograph of PCV2. Cell culture lysate preparations of PK-15 cells 
infected with fluids from PMWS affected pigs. The PCV2 is a 17 nm non enveloped 






Figure 3. Graphical representation of the PCV virion morphology. The virus is formed by 





The PCV1 and PCV2 are observed as 17 nm virion particles without an 
envelope (Finsterbusch et al., 2009, Ramamoorthy et al., 2009). The virus 
encapsidates the closed circular single stranded genome molecule. The PCV1 has 
a genome size of 1759 nucleotides and the PCV2 has a genome size of 1767/68 
nucleotides. 
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The entry and replication of the PCV virus has been studied in porcine 
origin cell culture models using PK-15, an epithelial cell line and 3D4/31, a 
transformed monocyte lineage cell line (Misinzo et al., 2006). Other cell lines 
such as porcine origin L34 cell line, monkey origin Vero cells, primary 
lymphocytes, cardiomyocytes, macrophage cells of porcine origin and 
macrophages of bovine origin also support PCV2 replication (Lefebvre et al., 
2008, Ramamoorthy et al., 2010, Rodríguez-Cariño et al., 2011). However, 
experimental infection of cells from avian or human origin did not yield a 
productive infection (Hattermann et al., 2004).  The virus enters the host cell by 
binding to chondroitin sulfate B and heparan sulfate glycosamino glycans on the 
cell surface (Misinzo et al., 2006). The subsequent internalization of the virus 
through the endosomal vesicles is dynamin- and cholesterol-independent, but 
requires actin- and small GTPases (Misinzo et al., 2009). Even though the virus is 
found in clathrin coated pits, depletion of clathrin deos not block the entry of the 
virus (Misinzo et al., 2009). Further, the release of the internalized virus from the 
endosomal-lysosomal vesicles is blocked by a serine protease inhibitor [4-(2-
aminoethyl) benzenesulfonyl fluoride hydrochloride] but not by aspartyl protease 
(pepstatin A), cysteine protease (E-64), and metalloprotease (phosphoramidon) 
inhibitors (Misinzo et al., 2008). Recently, the 2.3 angstrom atomic structure of 
the PCV2 Virus like particles (VLP) was determined and the heparin sulphate 
binding pocket could be identified (Khayat et al., 2011). Subsequent to the 
internalization, the genome is released in the cytoplasm from where it is 
transported to the nucleus where the single stranded genome is converted into a 
double stranded replicative intermediate (Ramamoorthy et al., 2010).  
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The single stranded DNA genome of the circoviruses has a very compact 
and efficient organization, it encodes for genes in both the sense and the antisense 
strands of the double stranded replicative intermediate. The PCV genomes have 
two major open reading frames (ORFs), the ORF1 in the sense strand, which 
codes for proteins involved in the replication of the virus genome, and the ORF2 
in the antisense strand, which codes for the capsid protein. A third ORF, the 
ORF3, is ensconced in the antisense strand of the ORF1. The replication of the 
genome takes place in the nucleus. The genome has a stem-loop forming sequence 
at the origin of replication, in between the two genes, ORF1 and ORF2, and a 
short intergenic region is present between the end of the ORFs (Fig. 4). The stem-
loop structure, is found to be structurally conserved in the origin of replication of 
many DNA viruses, phage genomes and plasmids (Cheung A K., 2007). The 
sequence to the 3’ end of the stem-loop structure has four hexamer repeats which 
serve as binding site for the replicase proteins (Fig. 4) (Steinfeldt et al., 2001, 
Cheung A K., 2007). The stem-loop structure, which harbours a conserved 
octanucleoide sequence (Oc8, Fig. 4), and the hexamer repeats found 3’ of the 
stem loop structure are identical between the PCV1 and the PCV2 except for two 
nucleotide positions in the 5’ part of the loop (Cheung A. K. 2004). The Replicase 
proteins of the PCV1 and PCV2 are experimentally shown to be interchangeable 
(Cheung et al., 2007). It is noteworthy that Rep proteins do not have any 
polymerase activity and should recruit the host DNA replication/DNA repair 
enzymes to replicate the genome. The replicase protein induces a nick near the 3’ 
end of the loop structure, in the octanucleotide motif Oc8, generating a free 3’ 
hydroxyl end and this initiates the replication of the genome (Steinfeldt et al., 
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2006). The genome is replicated by rolling circle replication with the help of the 
host DNA replication machinery (Cheung A. K. 2006). The unit length viral 
genome is generated by the nicking and subsequent ligation of the replicating viral 
genome by the replicase protein, which joins the new viral genome into a circular 
molecule (Steinfeldt et al., 2006). The single stranded genome is subsequently 













Figure 4. Origin of replication of the porcine circovirus. (Reproduced from 
Cheung et al., 2007). A conserved stem-loop structure is found at the origin of 
replication of PCV1 and PCV2, between ORF1 (Rep) and ORF2 (Cap). Oc8 
represents the octanucleotide sequence which contains the nick site, where the 
replicase proteins (Rep) encoded by the ORF1 induces a nick and generates a free 
3’ hydroxyl end to initiate replication of the genome. The sequence to the 3’ of the 
stem-loop structure contains the hexamer repeats CGGCAG which act as the 
binding site for the Rep proteins. The numbering of the nucleotide begins in the 








1.4 Transcriptome and proteome of PCV 
The transcriptome of PCV1 and PCV2 have been thoroughly analysed in a 
series of studies using 5’ and 3’ RACE (Rapid amplification of cDNA ends) 
cloning (Cheung A K., 2003 a, b). The transcription profiling of the PCV1 and 
PCV2 encoded genes has shown that the PCV1 encodes for 12 transcripts in total 
and the PCV2 encodes for 9 transcripts in total (Cheung A K., 2003b). The 
promoter regions of the ORF1 and ORF2 transcripts are found to the 5’ and 3’ of 
the stem-loop in the clockwise and counter clockwise orientations, respectively. 
The ORF1 transcript of the PCV1 and the PCV2 are processed into multiple splice 
variants which encode for different proteins involved in the replication of the virus 
(Replicase proteins; Rep), of which the Rep and Rep’ are essential for the 
replication of the virus (Fig.5 & 6) (Steinfeldt et al., 2001). The ratio of the Rep 
and the Rep’ transcripts and proteins are found to vary during the course of 
infection of the PCV1 and PCV2 virus, with a transient increase of the Rep’ 
compared to the Rep (Mankertz et al., 2004 and our unpublished observations). 
The promoter region of ORF1 has an Interferon stimulated response element 
(ISRE) which is shown to enhance the kinetics of the viral replication in cell 
culture upon addition of  Interferon α and Interferon γ (Ramamoorthy et al., 
2009b). All the Rep proteins have N terminal nuclear localization signal and 
localize to the nucleus where they mediate the replication of the viral genome. The 
atomic structure of the common N terminal region of Rep and Rep’ has been 
resolved (Vega-Rocha et al., 2007). The Rep and Rep’ proteins have three 
conserved rolling circle replication motifs “RCR motif” in their common N 
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terminal (Steinfeldt et al., 2006, Vega-Rocha et al., 2007). The Rep has a dNTP 
binding domain which is not found in Rep’.  
Table 1 
Amino acid region Domain 
4-18 Nuclear localization signal 
19-22 Rolling circle replication motif –I 
57-62 Rolling circle replication motif - II 
96-99 Rolling circle replication motif - III 
96 DNA cleavage active site 
Table 1. Functional domains of the Replicase protein (ORF1) 
The ORF2 transcript encodes the capsid protein and has its transcription 
start site in the middle of ORF1 gene (Fig. 5 &6) (Cheung et al., 2003 a, b, 
Mankertz et al., 2004). The capsid protein also has a N terminal multi-partite 
nuclear localization signal and the protein localizes to the nucleus at the initial 
stages of the virus morphogenesis. The assembled virus particles are initially 
found in the nucleus, but later are trans-located to the cytoplasm. Apart from the 
ORF1 and ORF2 encoded proteins, a novel protein of 104 amino acids, encoded 
by ORF3 located in the antisense strand of the ORF1, was identified in our 
laboratory (Liu et al., 2005). The PCV2 ORF3 begins at nucleotide at position 671 
and ends at 357.  It lies largely in the complementary to the intron of the ORF1. 





Figure 5. PCV2 transcriptome (Cheung et al., 2003a) 





Figure 6. PCV1 transcriptome (Cheung et al., 2003b) 
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1.5 Morphogenesis  
The morphogenesis of the PCV1 and PCV2 viruses begins with the virus 
genome replication that occurs in the nucleus. The viral genes are transcribed 
from the replicative intermediate and the capsid is translated in the cytoplasm. The 
capsid protein has a nuclear localization signal at its N terminal, which enables the 
protein to be transported to the nucleus (Shuai et al., 2011). The initial virus 
assembly occurs in the nucleus. Subsequently, the virions are translocated to the 
cytoplasm by where they form inclusion bodies (Rodríguez-Cariño et al., 2011, 
Stevenson et al., 1999). The electron microscopic observation of PK-15 cells 
persistently infected with PCV1 shows the replicated virus occuring as double 
membraned dense paracrystalline arrays in the cytoplasm (Stevenson et al., 1999). 
Similar crystalline aggregates of the PCV2 have been found in the lymphnodes of 
pigs with PMWS (Onuki et al., 1999). A recent study of PCV2 morphogenesis in 
a lymphoblastoid L34 cells also shows that the virus replication occurs in phases 
and is accumulated as membraned crystalline arrays in the cytoplasm (Rodríguez-
Cariño et al., 2011). All the ultrastructural observations show that the virus 
particles have a tendency to get accumulated in the host cells (Stevenson et al., 
1999, Rodríguez-Cariño et al., 2011). In the nucleus PCV2 virions assemble as 
inclusion bodies, which are not enveloped, and occur in the periphery close to the 
nuclear membrane. The virus particles assembled in the nucleus enter the 
cytoplasm by budding of the nuclear membrane. The inclusion bodies in the 
cytoplasm are bound by a double membrane and their size may reach upto 1 
micron in diameter. Eventually, the virus aggregates in the cells cytoplasm are 
released by lysis of the infected cells (our observations).  
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1.6 Epidemiological history of porcine circovirus infections 
The PCV1 and PCV2 antigens and genome have been identified in 
archived porcine tissue prior to the emergence of PMWS in many countries (Firth 
et al., 2009, Grierson et al., 2004). The early cases of the association of the virus 
with PMWS were reported in Canada in the late 1990’s (Clark et al., 1996, Ellis J 
et al., 1998, Hamel et al., 1998, Harding, J. C., 2004, Nayar et al., 1997). Since 
then the virus has been identified around the globe in domestic and wild pigs. 
Among the various strains of PCV2, and even among PCV1 and PCV2, the ORF1 
encoded replicase proteins have a high degree of protein homology. On the other 
hand, the PCV2 has been classified into many phylogroups based on the 
polymorphisms in the ORF2 gene coding for the capsid proteins (Cheung et al., 
2007, Firth et al., 2010, Hughes et al., 2008). Of these, the two major phylogroups 
are the PCV2a and PCV2b. Cheung et al., (2007) has defined short amino acid 
motifs which could be used to distinguish the PCV2a and PCV2b. The motifs 
located from amino acid positions 86 to 91 and 190-191-206-210 of the ORF2, are 
highlighted as the signature motif 1 and 2 respectively (Cheung et al., 2007, 
2011). The signature motifs in PCV2a are; motif 1, TNKISI and motif 2, SR-K-D 
and in that of the PCV2b is; motif 1, SNPRSV and motif 2, AG-I-E. Many studies 
across the globe, in North America, Switzerland, Denmark, Spain, China, Korea 
have shown that the PCV2b groups has become more prevalent in the last few 
years (Cortey et al., 2011, Dupont et al., 2008, Gagnon et al., 2007, Guo et al., 
2010, Lyoo et al., 2008, Wiederkehr et al., 2009) . A recent study by Cheung et 
al., (2011) describes the role played by “signature motifs” in the replication 
efficiency of the virus. The motif 2 of the PCV2b enables a comparatively robust 
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replication of the virus carrying this motif. Moreover, the PCV2b are more 
frequently isolated in the PCVAD conditions than the PCV2a (Firth et al., 2009). 
Another retrospective epidemiological study conducted in Sweden, on the 
association of polymorphisms in the genome of PCV2 with the disease status in 
the herd from which the virus was isolated also indicates that the PCV2b 
predominates in the endemically diseased herds (Timmusk et al., 2008). 
Interestingly, in addition to the correlation of PCV2b isolation and disease status 
of herds, this study also reveals that certain aminoacids variations in ORF3 are 
also associated with PMWS in the herds. Especially the positions 14, 29, 41 and 
102 of the ORF3 varied between the PCV2a and PCV2b groups. This study lends 
clue to the role of the ORF3 protein in the pathogenesis of PCV2. Yet another 
interesting association with regard to the polymorphisms in ORF2 is the presence 
of the PCV2a group in Australia without any incidence of PMWS for many years 
after the initial outbreak of PMWS in North America (Firth et al., 2009, Muhling 
et al., 2006). However, recent reports indicate the sporadic occurrence of PMWS 
also in Australia.  
1.7 Evolutionary aspects of circoviruses 
Analysis of the evolutionary features of the porcine circovirus reveals 
many interesting insights (Firth et al., 2009, Hughes et al., 2008). First of all the 
PCV2 genome has a high rate of nucleotide substitution of 1.2 x 10-3 
substitutions/site/year, approaching that of RNA genome viruses and it is the 
highest for any ssDNA viruses (Firth et al., 2010). This could be due to the small 
genome of the PCV2 (1.7kb) and hence the error tolerating capacity is high in 
accordance with the error threshold theory. Also, the small genome and rapid 
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replication may allow for the accumulation of neutral or beneficial substitutions 
(Firth et al., 2009). An early study by Gibbs et al., (1999) speculates that the Rep 
protein of the circoviruses were derived by a recombination of a plant virus, 
Nanovirus, and an animal virus, Calcivirus, during a plant to animal host jump by 
the Nanovirus genome. The ORF1, which exhibits low nonsynonymous 
nucleotide polymorphisms, is thought to be under purifying selection, whereas the 
ORF2 shows more diversity, as already discussed (Firth et al., 2009, Hughes et al., 
2008). The phylogenetic and co-phylogenetic correlations and inferences of the 
various vertebrate and avian circoviruses and their hosts indicate that the avian 
circoviruses and vertebrate circoviruses diverged recently about ~500 years ago 
(Firth et al., 2009). However, the host avian and vertebrate species have diverged 
300 million years ago. This indicates that the circoviruses experienced a host jump 
from avian to vertebrate species ~ 500 years ago, with a possible involvement of 
wild swine populations. The PCV1 and PCV2 are thought to have diverged about 
100 years ago. Further, the time to most recent common anscestor (TMRCA) for 
different strains of PCV2b is estimated to be around 20 years ago, which neatly 
fits with the epidemiological history of the emergence of PCV2 diseases (Firth et 
al., 2009). However, TMRCA of PCV2a population is 43 years ago and this 
shows that the PCV2a and PCV2b have independent lineage and have been co-
circulating and independently evolving among swine populations. The analysis of 
PCV genome nucleotide substitution patterns by Firth et al., (2009) further 




1.8 Transmission of the virus 
Experimental observations have shown that PCV2 has a high degree of 
thermal stability and are only partially inactivated by the standard pasteurization 
procedures (O’ Dea.et al., 2008, Welch et al., 2006). Further, the ability of the 
non-enveloped PCV2 to withstand harsh environmental conditions may be a factor 
which has enabled its spread ubiquitously throughout the world. Indeed, estimated 
diffusion pathways (routes of spread) based on phylogenetic analysis show that 
the pathogenic virus has spread from North America to various continents in a 
short time due to the global trade (Firth et al., 2009). PCV2 infection is accquired 
by oro-nasal mucosal route and the virus is shed in all the secretions and 
excretions of the pigs (Ramamoorthy et al., 2009). The virus is distributed by the 
lymphatic system and blood to all organ systems and, as mentioned earlier, can 
replicate in a wide variety of organs, including liver, kidney, cardiomyocytes, 
lymphoid cells, epithelial cells, reproductive organs, e.t.c. Infected pregnant sows 
pass the virus vertically to the foetuses, which may cause abortion or stillbirth. 
1.9 Model of the PCVAD development 
 The PCV2 presents a peculiar association with the PMWS and other 
PCVADs. The PCV2 is necessary for the development of PMWS, but some 
experimental infection studies and viral isolations in apparently healthy pigs have 
shown that the PCV2 may not be sufficient to induce the condition (Ramamoorthy 
et al., 2009). The age of onset of the PMWS, 3 weeks, correlates with the waning 
maternal antibody levels seen in the weanling piglets. Immune stimulation in the 
form of vaccination, or other infections due to decrease of maternal antibodies 
may contribute to the development of the PCVADs (Krakowka et al., 2002). The 
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salient features of the PMWS affected pigs are the high viremia, lymphoid 
depletion, characteristic pathological lesions and presence of co-infections 
(Darwich et al., 2004; Harding et al., 2008; Krakowka et al., 2002; Sanchez et al., 
2004; Stevenson et al., 2001;Wallgren et al., 2009). The high viremia could reflect 
the failure of the animal’s immune defences, due to lymphoid depletion, to control 
the virus replication. The development of the PCVADs can be modelled as below. 
 
 








1.10 Host Virus interaction 
Viruses are cellular parasites that use the host cell for their replication. In 
this process, they interact with many cellular proteins 
(http://expasy.org/viralzone.html). Some viruses like Poxviruses and 
Baculoviruses have a large genome and encode for many proteins, which either 
directly play a role in their replication (viral polymerases or translation initiators) 
or act indirectly by suppressing or subverting host cells processes. Other viruses, 
such a Parvoviruses and Circoviruses, have small genomes and depend largely on 
the host cell proteins for their replication. On the same note, the host animals and 
their cells have evolved a variety of mechanisms and processes to fight against the 
viral parasites. The immune system of the animal host plays a major role in the 
elimination of the viral pathogens. A brief overview of the vertebrate immune 
system, especially how it responds to a viral infection would be beneficial for this 
thesis. The major arms of the host immune system are the innate immune system 
and adaptive immune system. The innate immune system is the “fast deployment 
arm” and consists of secreted molecules in mucosal tissue, circulating molecules, 
cell surface receptors, motile phagocytic cells, etc. The adaptive immune system is 
the pathogen specific and a more comprehensive defence mechanism, which 
protects against future episodes of infection by the same pathogen. The adaptive 
immune arm consists of functionally distinct types of cells, that can be described 
as phagocytic cells, antigen-presenting cells, and antigen sensing cells, which 
respond to specific antigens. Principle among the antigen sensing cells are the B 
and T lymphocytes. All the different cell types secrete numerous molecules 
(cytokines and chemokines) which determine the nature of the adaptive immune 
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response. Independent of the immune response, the host cells - epithelial cells, 
immune system cells - have an array of cellular processes to fight against the viral 
parasites and other microorganisms. The type I interferons (Interferon α and β), 
the proteins that regulate their expression (Interferon regulatory factors, IRF) and 
other genes that are stimulated by the interferons (Interferon stimulated genes) 
form the major host cell innate antiviral processes (Perry et al., 2005). The type I 
interferon expression is stimulated by pathogen associated molecular pattern 
(PAMP) sensing receptors which are situated on the cell surface like (Toll like 
receptors; TLR, Nod like receptors; NLR) and in the cytoplasm (Rig-1 like 
receptors, RLR). These receptors are stimulated by virus associated molecular 
patterns like dsRNA, CpG DNA motifs, viral glycoproteins, etc. The type I 
interferon response serves to prevent or limit the viral replication by partially 
shutting down the infected cells and the neighbouring cells. This is brought about 
by toning down many cellular processes including the transcriptional, 
translational, protein turnover, apoptotic mechanisms, etc. The type I interferons, 
which are secreted, are also an important link to the adaptive immune system. 
Apart from the interferon system, the viral proteins are also targeted by the host 
cellular protein turnover mechanisms such as the ubiquitin pathway, unfolded 
protein response mechanisms (UPR) and autophagy pathways (Dreux et al., 2010, 
Shackelford et al., 2005). In turn, the viruses also subvert these mechanisms for 
their benefit. Another major response of the host cells to viral infection is the 
induction of apoptosis. If the virus infected cell undergoes apoptosis immediately 
upon infection, the virus replication is curtailed, whereas if the virus is non-lytic 
and the apoptosis occurs after sufficient virus replication, it could serve to spread 
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the viral infection (Best et al., 2008, Everett et al., 1999). The role of ubiquitin 
pathways and apoptosis in viral infection are discussed in detail in later chapters. 
   The PCV2 genome replication is brought about by two viral proteins Rep 
and Rep’ and is largely dependent on host factors. Yeast and bacterial two hybrid 
assays, to study protein protein interactions, have identified a number of proteins 
that interact with the viral proteins (Table 2) (Finsterbusch et al., 2009b, Liu et al., 
2007, Timmusk et al., 2006). The ORF1 or the ORF2 proteins, when over 
expressed in porcine origin PK-15 cells do not cause any ill effects (Liu et al., 
2005). However, the ORF3 is known to cause apoptosis when over expressed in 
PK-15 cells (Liu et al., 2005). The ORF1 and ORF2 protein interactions with the 
host cellular proteins are probably associated with the replication and 
morphogenesis of the virus. Considering the apoptosis inducing nature of ORF3, 
its host interaction is of potential interest in understanding the molecular 
pathogenesis of the virus. The interaction of ORF3 with cellular protein pPirh2 
(porcine p53 induced RING-H2) was identified in our laboratory by yeast two 
hybrid assay (Liu et al., 2007). The third chapter of this thesis describes in detail 
the nature of the interaction and its role in the molecular pathogenesis induced by 
the virus. Other studies reporting host genes that are differentially expressed upon 
PCV2 infection reveal that most of these genes are involved in the immune 
response (especially innate immune response) of the host, signal transduction and 
cellular transport processes and could not be directly linked to any pathogenic 
processes induced by the virus (Bratanich et al., 2006, Finsterbusch et al., 2009, 




Viral Protein Cellular interacting protein Publication 
Syncoilin Timmusk et al., 2006 
c-myc Timmusk et al., 2006 
ZNF265 Finsterbusch et al., 2009b 
TDG Finsterbusch et al., 2009b 
Rep protein 
VG5Q Finsterbusch et al., 2009b 
p-selectin Timmusk et al., 2006 
C1qB Timmusk et al., 2006 
gC1qR Finsterbusch et al., 2009b 
MKRN1 Finsterbusch et al., 2009b 
Par-4 Finsterbusch et al., 2009b 
NAP1 Finsterbusch et al., 2009b 
Hsp40 Finsterbusch et al., 2009b 
NPM1 Finsterbusch et al., 2009b 
Cap protein 
DDE-like transposase Timmusk et al., 2006 
Membrane RGS16 Timmusk et al., 2006 
ORF3 
pPirh2 Liu et al., 2005 
 
Table 2. Host proteins identified to interact with PCV2 proteins by Bacterial and 






 As mentioned earlier, the PCV2 virus is known to modulate host cell 
innate immune response genes (Tomas et al., 2010, Wikstrom et al., 2011).  PCV2 
infection is also characterized by altered cytokine profile at the systemic level 
(Darwich et al., 2003, Shi et al., 2010, Sipos et al., 2005, Stevenson et al., 2006). 
These effects of the PCV2 are largely mediated by the non-genetic information in 
the viral genome, rather than the viral genes themselves. The PCV2 genome 
consists of sequence motifs, like CpG motifs and other secondary structure, some 
of which can inhibit the Type I interferon secretion by epithelial and porcine 
Peripheral blood monocyte cells (poPBMCs) and also enhance the IL-10 secretion 
by poPBMCs (Kekarainen et al., 2008, Vincent et al., 2005, Wikstrom et al, 2007, 
2011).  
1.11 Thesis outline 
Publications on the virulence determinants in PCV2 infections are few and 
they implicate the polymorphisms in the ORF2 and ORF3 of the PCV2 (Cheung 
et al., 2007, Fenaux et al., 2004, Firth et al., 2009, Timmusk et al., 2006). 
However, like any other infectious disease, factors such as host genetic 
susceptibility, environmental conditions and animal husbandry conditions also 
play a role in determining the pathogenicity of the PCV2 infection (Ramamoorthy 
et al., 2009). This thesis describes the role of ORF3 in the pathogenesis of the 
PCV2 virus infection at the systemic and cellular level (Karuppannan et al., 2009, 
2010, 2011). Our laboratory identified the ORF3 to cause apoptosis during virus 
infection of PK-15 cells, but not essential for virus replication (Liu et al., 2005). 
Subsequent analysis using yeast two hybrid studies revealed that ORF3 interacts 
with a cellular protein known as “porcine homologue of p53 induced ring 
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homology domain 2” (pPirh2) (Liu et al., 2007, Karuppannan et al., 2009). The 
body of work described in this thesis can be delineated into three parts; the first 
part comprises the characterization of the role of PCV2 ORF3 in the infection of 
its natural host, the piglets (Karuppannan et al., 2009). This study was essential as 
it qualified the further detailed analysis of the role of ORF3 in the pathogenicity of 
PCV2. The study was conducted using Specific Pathogen Free (SPF) piglets as a 
host. The SPF experimental animals are maintained in high bio-security housing 
conditions and are devoid of a specified list of pathogens. The SPF piglets are 
usually borne by caesarean section and are not fed their mother’s milk. The SPF 
piglets offer the advantage of absence of any background pathogenic micro-
organism which can skew the effects of the experimental pathogen, PCV2. Our 
results from the experimental infections showed that ORF3 indeed plays a major 
role in the pathogenicity of PCV2. In the second part of the work, the cellular and 
molecular mechanism by which ORF3 causes the apoptosis of the PCV2 infected 
cells were characterized. Our findings on the molecular activity of ORF3 have 
also led us to speculate other potential uses for the protein. In the third part of the 
thesis, the role of ORF3 mediated apoptosis in the egress of PCV2 from infected 
cells and systemic spread of the PCV2 infection with reference to the host 
response was analysed. The findings from these studies enunciate the role of 









Ablation of ORF3 expression from porcine circovirus 2 leads to the 



















Porcine circovirus Type 2 (PCV2) is the primary causative agent of 
naturally occurring Postweaning Multisystemic Wasting Syndrome (PMWS) 
(Allan et al., 1998, 1999; Meehan et al., 1998). This condition has been 
experimentally reproduced in gnotobiotic, specific pathogen free (SPF) and 
conventional pigs (Allan et al., 2004; Magar et al., 2000; Okuda et al., 2003) and 
BALB/c mice (Kiupel et al., 2001, 2005; Liu et al., 2006). To recapitulate the 
characters of PCV2 infection and associated syndromes, they are usually observed 
in piglets in the postweaning stage of 5 to 18 weeks of age. In affected farms 5 to 
20% of the piglets are infected and up to 80% of the affected piglets succumb 
(Darwich et al., 2004). The PMWS is characterized by progressive weight loss, 
dyspnoea and generalized lymphoid depletion, altered cytokine profile and 
reduced cytokine production in affected pigs (Darwich et al., 2002, 2004; Nielsen 
et al., 2003; Segales et al., 2004; Shibahara et al., 2000). Pathogenesis of PMWS 
is characterized by lymphopenia with a downshift of CD4 helper T lymphocytes, 
CD8 cytotoxic T lymphocytes, CD4 and CD8 double positive lymphocytes and 
IgM positive B-lymphocytes. These are believed to be indicative of an impaired 
immune system in the infected piglets (Darwich et al., 2002, 2004; Nielsen et al., 
2003; Segales et al., 2004). BALB/c mice infected with PCV2 show microscopic 
lesions indicative of lymphoid depletion and destruction of the architecture of the 
lymphoid organs (Kiupel et al., 2001, 2005; Liu et al., 2006). However, the 
infected mice do not display any observable disease. The compact genome of 
PCV2 encodes five splice variants of the gene for the Replicase protein (ORF1), a 
Capsid protein (ORF2), ORF3 and other computationally predicted ORFs 
 28 
(Cheung, 2003). Our laboratory identified the non-structural protein encoded by 
the ORF3, which causes apoptosis in PCV2 infected cells (Liu et al., 2005, 2006). 
However, ORF3 protein is not necessary for the replication of the virus. ORF3 has 
been shown to interact with pPirh2 (porcine p53 induced RING-H2), porcine 
homologue of the E3 ubiquitin ligases Pirh2 and hPirh2 (humanPirh2) of mice and 
humans, respectively (Liu et al., 2007). This interaction causes a decrease in 
degradation of the tumor suppressor p53 by pPirh2, leading to accumulation of 
p53 that eventually causes apoptosis of PCV2 infected cells. Bacterial two hybrid 
screens have identified other interacting partners for ORF3, notably among them 
is the RGS16, a regulatory protein involved in the signalling by G proteins 
(Timmusk et al., 2006). Genetic engineering of the PCV2 genome to knock out 
the expression of ORF3 presents as a rational approach to evaluate the role of 
ORF3 in the pathogenesis of PCV2. A single nucleotide mutation to knock out the 
ORF3 protein expression proved to attenuate the PCV2 in vitro and in vivo in 
mice (Liu et al., 2006).  This chapter describes the experimental inoculation of a 
genetically engineered ORF3 deficient PCV2 in SPF piglets and illustrates the 









2.2 Materials and methods 
2.2.1 Viruses and cell culture 
The PCV2 were grown in PK-15 C1 cell line of porcine origin which was 
free of PCV1 contamination, and supports high titer of virus replication (Zhu et 
al., 2007). The cells were maintained in minimal essential medium supplemented 
with 5% heat inactivated fetal bovine serum (FBS), 5% L-glutamine, 100 U/ml of 
Penicillin G, and 100 µl/ml streptomycin at 37 C in a humidified 5% CO2 
incubator. The PCV2 virus, designated BJW strain, and mutants from this strain 
used in the study were isolated from kidney tissue of pigs with a natural PMWS 
condition from the Northern region of China (Liu et al., 2005). The PK-15 cells 
were treated with 300 mM Glucosamine after infection with PCV2 to increase the 
infectivity of the virus (26, 41). The virus titer was estimated by 
Immunofluorescence assay using polyclonal antibodies against ORF1 protein as 
described previously (Liu et al., 2005).  
2.2.2 Generation of Mutant viruses and their characterization  
The mutant PCV2 viruses were generated as described previously (Liu et 
al., 2006). Briefly, computational analysis of overlapping sequence of ORF1 and 
ORF3, on the opposite strands of the PCV2 genome, was performed to find out 
mutable sites on ORF3 without affecting the ORF1 amino acid sequence. The 
degenerate codes for the overlapping region of ORF1 and ORF3 on the opposite 
strands were aligned to identify redundant common bases. Next, individual or 
multiple mutations were introduced in the selected redundant codons in sequence 
of PCV2 genome, such that the ORF1 coded amino acids were maintained but the 
ORF3 coding sequence acquired a mutation of the start codon or a premature stop 
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codon (Table 1). The mutations were introduced in the cloned PCV2 genome 
inserted in pBlueScript SK vector using the QuickChange site-directed 
mutagenesis kit (Stratagene, La Jolla, CA, USA) according to the kit instructions. 
The mutated genomes were then cloned in DH5α E. Coli. The viruses were then 
regenerated from the mutated genome vector as described previously, using the 
transfection reagent Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) (Liu et 
al., 2006). The regenerated viruses were serially passaged in PK-15 cells three 
times. The virus stock was titrated and used to infect an overnight culture of PK-
15 cells (at 60–70% confluency) at an MOI of 1 TCID50. 5 ml of the diluted virus 
supernatant was used to infect a surface area of 25 cm2. The virus infected cells 
were cultured for 3 days before they were analyzed for virus induced cell death. 
Controls of uninfected PK-15 cells and wildtype PCV2 infected cells were used. 
All the infections were performed in triplicates. The genetic stability of the double 
mutant viruses after 60 passages in PK-15 cells or 42 days after infection in 
BALB/c mice was verified as follows. Briefly, the virus genome was isolated 
from cells or serum using the QIAamp DNA Minikit (QIAGEN, Germantown, 
MD, USA). The isolated genome was amplified using the primers F-PCVPST (5-
TGCACTGCAGTAAAGAAGGCAACTTAC-3) and reverse primer R-PCVPST 
(5-TGCACTGCAGTATTCTTTATTCTGCTG-3) and inserted into pBlueScript 
SK vector and cloned in DH5α E. Coli. At least 15 clones of each of the mutant 





2.2.3 Yeast two hybrid assays 
The molecular interaction between Pirh2 and mutant ORF3 were assayed 
in a yeast two-hybrid assay system (Matchmaker GAL4 Two- Hybrid System 3; 
Clontech, Mountain view, CA, USA). The interacting proteins were cloned in the 
pGAL or pGBK vectors and co-transformed in into yeast strain AH109, and the 
transformants were selected on synthetic defined SD/His−/Leu−/Trp−-5-bromo-4-
chloro-3-indolyl-β-Dgalactopyranoside medium and SD/Ade−/His−/Leu−/Trp−-5-
bromo-4-chloro-3-indolyl-β-D- galactopyranoside medium. The interacting 
proteins showed as blue colonies of various sizes. The vectors pGBKT7-53 and 
pGADT-7 were used as positive controls for galactosidase activity. 
2.2.4 Antibodies and recombinant proteins 
The polyclonal antibodies against ORF1, ORF2 and ORF3 used in the 
experiments were produced in our laboratory (Liu et al., 2005, 2006). The ORF1, 
2 and 3 were cloned in the expression vector pQE30 and proteins were expressed. 
The purified proteins were injected, separately, into mice by intraperitoneal route 
to raise polyclonal antibodies. The recombinant ORF2 protein used in the 
serological assays is a fragment of the wild type ORF2 protein (a 28 amino acid 
peptide spanning 113–140 amino acid residues of ORF2). The sequence of ORF2 
coding the fragment was cloned in expression plasmid pGEX-4T-1 and expressed 
in E. coli strain (BL21) and purified.  
2.2.5 Experimental design 
The animal experiments were conducted with colostrum deprived 3 week 
old SPF piglets delivered by C-section (Animal Technology Institute (ATIT), 
Miaoli, Taiwan, R.O.C). The piglets were randomly divided into two groups of six 
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piglets each and housed and managed separately in two different bio-containment 
rooms at Animal Health Research Institute (AHRI), Tansui, Taiwan, R.O.C. The 
animals were screened for the presence of PCV2 genome in serum by Quantitative 
Real time PCR and for the presence of antibodies against PCV2 by ELISA as 
described below. All the piglets showed negative in both the assays. The group 1 
received an inoculation of 1 ml of 106 TCID50 of the double mutant PCV2 virus 
lacking the ORF3 expression, intramuscularly in the neck region. The group 2 was 
inoculated with 1ml of 106 TCID50 of the wildtype virus. Serum sample and 
heparinized blood sample were obtained on days 7, 14, 21, 28 and 35 for analysis 
of viremia and PCV2 specific antibody titer and flow cytometric analysis 
respectively. Daily observation of the temperature and physical health of the 
piglets was performed. The piglets were euthanized on day 35 after the 
inoculation and necropsy was performed. Organs and lymphnodes were collected 
from the pigs for histological analysis. 
2.2.6 Serological analysis 
The levels of serum antibodies against PCV2 ORF2 were determined by 
an indirect ELISA using the recombinant GST-ORF2 fusion protein mentioned 
above. 50 ng of recombinant ORF2 (expressed in E. coli) was coated on to the 
plates and 1 in 100 dilution of serum was used for the Indirect ELISA. Sera which 
showed at least two standard deviations more optical density, at 490 nm, than the 
mean of negative control sera were considered as sero-positive to ORF2 of PCV2. 
2.2.7 Quantitative real time PCR 
Briefly, viral genome was isolated from 100 µl of serum using the 
QIAamp DNA Minikit (QIAGEN, Germantown, MD, USA) and the copy number 
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was estimated by using LightCycler ® real time PCR machine (Roche Applied 
Sciences, Indianapolis, IN, USA) and DyNAmo™SYBR® Green qPCR Kit 
(Finnzymes, Espoo, Finland). The primers used were specific for ORF2 in the 
PCV2 genome and amplified a 250 bp region. The primers and PCR parameters 
are the same as described earlier (Liu et al., 2006). 
2.2.8 Histology 
Samples of inguinal nodes were collected and fixed in formalin, embedded 
in paraffin blocks cut at 2–4 µm (Leica Autocut microtome model 2255, Leica 
Microsystems, Wetzlar, Germany) and attached to poly-L-lysine coated glass 
slides. Slides of 4 µm were used for staining with hematoxylin and eosin (H&E). 
Furthermore, an immunohistochemistry (IHC) technique was used to detect the 
presence of viral antigen by using a monoclonal anti-ORF2 antibody. Briefly, 
slides of 2 µm were de-paraffinized using Histo-choice (Amersco, Solon, Ohio, 
USA) and rehydrated in sequentially graduated ethanol baths, and then 
endogenous peroxidase activity was inactivated. For antigen retrieval, sections 
were pressurized in 10 mM citric acid (pH 6.0) at 120 °C for 5 minutes. Slides 
were rinsed in PBS then blocked in 0.1% non-fat milk in PBS for 30 minutes and 
then incubated with monoclonal antibody(s) for 2 h at room temperature, followed 
by three 5 minutes washes in PBS. Slides were incubated with labeled polymer-
HRP anti-mouse (Dako Cytomation, Glostrup, Denmark) for 30 min, washed with 
distilled water and then incubated with AEC+chromogenic substrate (Dako 
Cytomation) for another 30 minutes. The substrate was washed off with distilled 
water and the slides were counter stained with Lillie–Mayer hematoxylin for 1 
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min and then mounted using aqueous mounting media. Non-specific mouse 
monoclonal antibody was used as negative control. 
2.2.9 Flow cytometry 
Peripheral blood lymphocyte analysis was performed with Becton 
Dickinson FACScalibur instrument (BD Biosciences, San Jose, CA, USA). 
Peripheral blood from piglets was collected into heparinized collection tubes. The 
sample preparation was performed with Uti-Lyse Kit from DakoCytomation 
according to the manufacturer's instructions provided in the kit. The lymphocytes 
were stained with mouse anti pig IgM followed by a secondary antibody 
conjugated with FITC or mouse anti pig CD4a FITC and mouse anti pig CD8a PE 
conjugated antibodies (Pharmingen, BD Biosciences) for 1 h in the dark. At least 
10,000 events, gated on the lymphocytes based on the FSC and SSC profile, were 














2.3.1 Mutations and genetic stability of the virus  
In order to understand the biochemical nature of ORF3, computational 
prediction of the ORF3 secondary structure was performed. The prediction 
showed the presence of prominent alpha helical regions and beta strands (Fig.8A). 
A panel of five mutant PCV2 with mutations (Table 3) in the ORF3 gene, to 
prevent the translation or disrupt the secondary structure, were designed and 
produced by site-directed mutagenesis and reverse genetics, as described in the 
Materials and methods section. The mutants were designed such as not to affect 
the amino acid sequence coded by the ORF1 of all the mutant viruses (Table 3). 
The expression of ORF1 by the mutant viruses were confirmed by indirect 
immunofluorescence assay (IFA) staining with anti-ORF1 specific antibodies in 
mutant virus infected cells (data not shown). The different mutants had a 
comparable titer and pattern of growth kinetics in PK-15 cells (data not shown). 
PK-15 cells were infected with the mutant viruses and screened for cell death by 
light microscopy (Fig. 8B) at 72 h post infection. The ATG mutant, as already 
observed (Liu et al., 2006), and the mutant 27 and mutant 61 showed only 10% 
cell death as compared to 80% cell death in the wildtype virus. The mutant 52 and 
mutant 85 still induced 80% or more cell death in infected cells. The mutations in 
the ATG mutant and mutant 27, independent of each other in preventing the full 
length ORF3 protein expression and the subsequent ORF3 induced apoptosis, 
were combined and a double mutant virus was generated carrying a mutation of 
the start codon of the ORF3 from ATG to GTG with an additional mutation of the 
27th codon from Alanine to stop codon. This was predicted to act as a double 
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check to prevent the translation of a full length, functional ORF3 protein. The 
double mutant PCV2 also expressed the ORF1 protein as observed by IFA and 
produced only 10% cell death in infected cells (data not shown). The double 
mutant virus was serially propagated in PK-15 cells and the viral DNA was 
isolated after 60 passage numbers and the genetic sequence was analyzed. The 
results showed that the mutated genome sequence remained stable even after 60 
passages. The double mutant PCV2 virus was inoculated in BALB/c mice and the 
viral DNA was isolated from the serum of the double mutant inoculated mice on 
42 days post infection and the sequencing of the viral genome showed that the 

































































His His 10 




Ser Ser 10 




Val Val 80 




Phe Phe 10 




Val Val 90 
Percent cell death in wildtype PCV2 infected PK-15 cells, 4 days post infection. 80 
 
Table 3. A list of mutations in the ORF3 sequence of the generated PCV2 mutants 
and the effect of the mutants on infected PK-15 cells. Numbers 1 to 5 represent 
the ATG mutant, mutant 27, mutant 52, mutant 61 and mutant 85 respectively. 
The virus induced cell death in the wildtype PCV2 was 80% at 72 h after 
infection. The uninfected PK-15 cells showed only 10% cell death on the fourth 













Figure 8. Phenotype of ORF3 mutant PCV2 (A) The secondary structure of the 
ORF3 protein was predicted using the PsiPred secondary structure prediction 
method. H indicates alpha helix and E indicates beta strands. The amino acid 
sequence of the ORF3 is presented and the mutated sequences and secondary 
structure are indicated below. (B) Panels a–f show the cells infected (72 h post 
infection) with the wildtype PCV2 virus and the indicated mutants. a, Wildtype 
PCV2. b, ATG mutant. c, Mutant 27. d, Mutant 52. e, Mutant 61. f, Mutant 85. 
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2.3.2 Molecular interaction between ORF3 and Pirh2 
The above studies revealed that some of the mutant PCV2 viruses 
harbouring various mutations in the ORF3 sequence did not produce cell death to 
the same level as wildtype PCV2. To understand the molecular basis of the above 
observations, a series of truncated ORF3 expression constructs were generated. 
The codons 27, 51, 77, 88 and 96 spanning across the ORF3 were individually 
mutated to STOP codons, producing truncated ORF3 of different length. The 
binding of these truncated proteins to the porcine Pirh2 were then assessed using a 
yeast 2 hybrid system. The full length or truncated ORF3 were cloned into the 
pGAD GAL4 activation domain fusion vector and the Pirh2 was cloned in the 

















Figure 9. ORF3::Pirh2 yeast two hybrid assay. Yeast two hybrid assay of 
interaction between Pirh2 and truncated variants and full length protein of ORF3 
on synthetic defined SD/His−/Leu−/Trp−-5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside medium. The numbers 27, 51, 77, 88 and 96 indicate the length 













The results showed that the binding of ORF3 and Pirh2 are hindered only 
if ORF3 is less than 51 amino acids in length (Fig. 9, Table 4). The analysis of the 
degenerate genetic code of ORF3 and the overlapping complementary ORF1, in 
the PCV2 genome, showed that the second truncation mutation can still produce a 
functional ORF1 on the opposite strand, and the ORF3 in this case, is only 26 
amino acids in length. The observations from the yeast 2 hybrid assay confirmed 
that an ORF3 of only 26 amino acids cannot interact with Pirh2 to induce 
apoptosis in the mutant PCV2 infected cells, which explained the phenotype of the 
mutant PCV2 genomes. Further studies to elucidate the functional domains and 

















Growth on Construct 
SD/His−/Leu−/Trp− SD/Ade−/His−/Leu−/Trp− 
pGBK-Pirh2 only - - 
pGBK-Pirh2, pGAD-ORF3(1–26) - - 
pGBK-Pirh2, pGAD-ORF3(1–50) + - 
pGBK-Pirh2, pGAD-ORF3(1–76) + + 
pGBK-Pirh2, pGAD-ORF3(1–87) + + 
pGBK-Pirh2, pGAD-ORF3(1–95) + + 
pGBK-Pirh2, pGAD-FullORF3 + + 
 
Table 4. Yeast 2 hybrid assay showing the interaction between Pirh2 and ORF3 or 
its truncated variants on synthetic defined SD/His−/Leu−/Trp−-5-bromo-4-chloro-
3-indolyl-β-Dgalactopyranoside medium and SD/Ade−/His−/Leu−/Trp−-5-
















2.3.3 Characterization of the double mutant virus in vivo 
The evaluation of the pathogenicity of double mutant virus lacking ORF3 
was performed with three week old colostrum deprived SPF piglets, which were 
negative for the presence of PCV2 virus and antibody reactivity to PCV2. The 
piglets were divided into two groups of six each, the group 1 piglets were 
inoculated with 1 ml of 106 TCID50 the ORF3 mutant virus and the group 2 
piglets were inoculated with 1 ml of 106 TCID50 wildtype PCV2 virus. 
Throughout the period of study, after the inoculation with either the ORF3 
deficient PCV2 virus or the wild type virus, the piglets in the group 1 and group 2 
did not show any clinical disease. Previous studies and observations by other 
groups indicate that co-infection with other pathogens or at least an 
immunostimulation to induce the lymphocytes to proliferate is necessary to trigger 
full blown clinical signs in PCV2 infected pigs (Allan et al., 2004; Krakowka et 
al., 2007; Ladekjaer-Mikkelsen et al., 2002; Nielsen et al., 2003). Samples of 
serum and heparinized whole blood were obtained from the piglets at weekly 
intervals. 
2.3.4 Serum viremia and virus specific antibody response 
The serum viremia in the piglets was estimated using quantitative real time 
PCR assay. All the piglets in both the group 1 and group 2 displayed serum 
viremia detectable by quantitative PCR assay starting from the first week after 
inoculation. The serum viremia in all the piglets in the group 1 peaked on day 14 
after inoculation with the mutant virus and declined on day 21 and could not be 
detected further (Fig. 11). The wildtype PCV2 virus inoculated group 2 piglets 
also displayed a peak viremia on day 14 after inoculation. The peak viremia in 
 44 
group 2 was one log fold higher than the viremia in group 1 piglets. The viremia 
in group 2 was protracted and was present till the end of the study period at low 
but detectable levels (Fig. 11). Five out of the six piglets in group 1 showed low 

























Figure 10. PCV2 specific antibody response. PCV2 specific average serum IgG 
antibody levels in the two groups of piglets observed at days 7, 14, 21, 28 and 35 
after inoculation. An indirect ELISA was used to quantitate the PCV2 specific 
serum antibody levels. The optical density at 490 nm is indicated along the Y axis. 
Group 1 (open columns) was inoculated with the ORF3 deficient PCV2. Group 2 
(shaded columns) was inoculated with the wildtype PCV2. The height of each 






















All the piglets in group 1 had sero-converted on day 14 after inoculation 
and peak levels of serum PCV2 specific IgG were observed on this day. All the 
piglets in group 2 had low levels of serum PCV2 specific IgG levels on day 7 and 
the PCV2 specific IgG levels peaked on day 14 after inoculation (Fig. 10). The 
group 1 piglets showed a higher peak level of PCV2 specific IgG level than group 
2 piglets on the day 14 after inoculation. The PCV2 specific IgG antibody levels 
persisted in both the groups till the end of the study, although the levels in group 1 
were higher than the levels in group 2 on all days tested. Moreover, the variation 
in the PCV2 specific IgG levels among the individual piglets in group 2 was high 


















Figure 11. Wildtype and ORF3 mutant PCV2 serum viremia. The average serum 
viremia levels in the two groups of piglets at days 7, 14, 21, 28 and 35, detected 
by real time quantitative PCR assay and expressed as log 10 copy numbers per ml 
of the serum. Group 1 (open triangles) was inoculated with the ORF3 deficient 
PCV2. Group 2 (shaded triangles) was inoculated with the wildtype PCV2. Each 















2.3.5 Lymphocyte counts 
Lymphoid depletion is a hallmark of PCV2 associated diseases. Peripheral 
blood IgM positive B lymphocyte, CD4 positive and CD8 positive T lymphocyte 
counts of the piglets were estimated by flowcytometry (Figs. 12A–D). Prior to 
inoculation with the PCV2 mutant or the wildtype virus, the group 1 and group 2 
piglets did not show any difference in the lymphocyte counts. The proportions of 
IgM positive B lymphocytes, CD4 positive T lymphocytes and CD8 positive T 
lymphocytes were elevated in group 1 compared with group 2. These observations 
show the perturbations in the lymphocyte counts occurring in the group 2, and a 
marked decrease in the number of B lymphocytes and CD4 T lymphocytes on the 
day 14 post challenge. However, the decrease in CD8 positive T cell counts in the 
group 2 was to a lesser degree than the decrease in IgM and CD4 positive cells. 
The CD4 and CD8 double positive cells are the memory T cells in the porcine 
species (Zuckermann and Husmann, 1996). A marked decrease in the proportion 
of memory T cell population was also observed in the group 2 piglets compared 
with group 1 piglets. Again, similar to the PCV2 specific antibody levels, we 
observed that the variation in the lymphocyte counts of individual piglets in group 











Figure 12. Peripheral Blood Lymphocyte quantification. Flowcytometric analysis 
of peripheral blood lymphocyte (PBL) in the piglets. The numbers are expressed 
as percent (%) of cells in the PBL. A, B, C, D shows the percent of IgM, CD4, 
CD8 and CD4 and 8 lymphocytes, respectively, in peripheral blood obtained from 
the piglets. The analysis was performed after RBC lysis and staining for the 
surface markers. 10,000 events, gated on the lymphocytes based on FSC and SSC 
profile, were acquired using BD FACS Calibur machine and CellQuest software. 
Group 1 (blank rectangles) was inoculated with the ORF3 deficient PCV2. Group 
2 (shaded rectangles) was inoculated with the wildtype PCV2. The height of each 
rectangle represents the arithmetic mean value (n= 6)±standard deviation. (* — 
represents a statistically significant difference of p<0.05, **— represents a 
statistically significant difference of p<0.01, statistical differences were checked 





2.3.6 Histological findings 
The piglets in the group 1 and group 2 were euthanized and necropsy was 
performed on day 35 after challenge. At the time of euthanasia, the group 2 piglets 
showed no clinical disease, but were unthrifty compared to group 1. Samples of 
liver, kidney, inguinal and mesentric lymph nodes and heart were collected from 
the piglets at the time of necropsy, for histopathology and immunohistochemistry 
examination. The necropsy showed nodulation and lymphadenopathy of 
mesenteric lymphnodes in group 2 piglets. Focal necrosis of liver and infarction of 
splenic edges was observed in two pigs from group 2 piglets but not in any animal 
from group 1. Arteritis and perivascular lymphoid infiltration are common 
histopathological findings in clinical PMWS. Immunohistochemical (IHC) 
analysis of the inguinal lymph nodes was performed to detect ORF2 antigen 
levels. The IHC analysis showed that significantly more viral antigens were 
detectable in many lymph node sections from group 2 piglets (Fig. 13B) when 













Figure 13. PCV2 specific ImmunoHistoChemistry. (A, B) The representative IHC 
staining of inguinal lymph nodes sections of piglets, inoculated with wildtype 
PCV2, obtained at the time of necropsy. ORF2 antigen-positive cells are red. (A) 
Lymph node section from a Group 1. Little staining is observed. (B) Group 2. 
Many ORF2 antigen positive cells are seen. Group 1 was inoculated with the 

















Figure 14. Histopathology. (A, B) The representative pictures of histopathologic 
appearance (hematoxylin and eosin) of inguinal lymph nodes derived from Group 
1 and Group 2 piglets at the end of the trial. (A) Normal morphology of inguinal 
lymph node section from a Group 1 piglet shows intact lymphnode architecture 
with well demarcated follicles. (B) The architecture of the lymphnode from a 
Group 2 piglet is lost, with absence of follicular areas. (C) A hematoxylin and 
eosin stained section of the medulla of kidney from Group 2 piglets with nephritis 
and cellular infiltration in the interstitial space. (D) A hematoxylin and eosin 
stained section of the liver from Group 2 piglets with histiocytic cellular 
infiltration. Group 1 was inoculated with the ORF3 deficient PCV2. Group 2 was 









The histological analysis of the sections of lymphnodes, kidney and liver 
of the group 1 and group 2 piglets revealed histopathology characteristic of PCV2 
infection only in group 2 piglets. The histology of kidney sections from group 2 
showed the presence of lymphoid infiltration of the interstitial space (Fig. 14C). 
The liver (Fig. 14D) and heart muscles (data not shown) of group 2 also showed 
signs of inflammation. The histology of the group 1 piglets revealed only a few 
isolated signs of histiocytic infiltration in the parenchymatous organs. The 
histological analysis of sections of mesenteric lymphnodes revealed that the tissue 
architecture of lymphnodes in group 2 has been destroyed (Fig. 14B), but not in 
group 1 where the follicles, the cortex and medulla are clearly seen(Fig. 14A). The 
formation of multinucleate giant cells, a characteristic of PCV2 pathology, was 
observed in the inguinal and mesenteric lymphnodes from group 2 piglets. The 
histological analyses gave an overall impression of a sub clinical manifestation of 













PCV2 is the causative agent of PMWS (Allan et al., 1998, 1999; Meehan 
et al., 1998). The pathogenesis of PMWS is characterized by multiple organ 
pathology including liver, lungs, kidneys and lymphoid organs, especially 
lymphoid depletion and histiocytic infiltration in lymphoid organs (Darwich et al., 
2004). The ORF3 protein encoded by the compact PCV2 genome has been shown 
to be involved in viral pathogenesis in a murine model (Liu et al., 2005, 2006). 
The ORF3 protein causes apoptosis in viral infected cells in vitro (Liu et al., 2005) 
and has functional analogy to the 14 kDa non structural protein VP3 (Apoptin) 
identified in Chicken anemia virus, another member of the Circoviridae (Noteborn 
et al., 1994). Infection with chicken anemia virus also causes immunosuppression 
and growth suppression in chicken (Jeurissen et al.,1992). The ORF3 of PCV2 
interacts with pPirh2, an E3 ubiquitin ligase known to be involved in the down 
regulation of the tumor suppressor p53 (Liu et al., 2007). Pirh2 is documented in 
humans to belong to the class of E3 ubiquitin ligases such as COP1 (Constitutive 
photomorphogenic 1) and Mdm2 (murine double minute 2), which are involved in 
the ubiquitin mediated proteasomal degradation of p53 (Corcoran et al., 2004; 
Leng et al., 2003; Yang et al., 2004). In another example, the human measles virus 
phosphoprotein is also known to interact with human Pirh2 (Chen et al., 2005). 
This interaction, similar to that between ORF3 of PCV2 and pPirh2, causes the 
change in the sub cellular localization of hPirh2 to cytoplasm. The interaction of 
PCV2 ORF3 with pPirh2 leads to the accumulation of p53 and subsequently the 
apoptosis of the infected cells. Many viruses are known to target p53 in the course 
of their infection to modulate its function (Devireddy and Jones, 1999; Dey et al., 
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2002; Dobner et al., 1996; Granja et al., 2004; Jault et al., 1995; Kovacs et al., 
1996). Mutant PCV2 virus lacking the expression of ORF3 or with a truncated 
ORF3, which cannot interact with pPirh2, would not lead to the accumulation of 
p53 in infected cells and does not cause apoptosis in infected PK-15 cells (Figs.7, 
8, Table 4). When inoculated in BALB/c mice, the mutant PCV2 lacking the 
ORF3 protein can replicate, although at lower levels compared to the wildtype 
virus (Liu et al., 2006). The mutant virus also elicits an immune response 
comparable to or marginally better than the wildtype infection. We hypothesize 
that the apoptosis induced by the ORF3 may be a factor which helps in the spread 
of the virus in vivo, even though it is not necessary for the replication of the virus. 
The PCV2 is known to be harbored in the macrophages and dendritic cells 
(Darwich et al., 2004), which may play a role in the dissemination of the virus 
from the apoptotic cells. Viruses code proteins which can favor or inhibit 
apoptosis (Roulston et al., 1999). Many viruses are known to manipulate the host 
apoptotic machinery to enhance their replication, evade the immune system and 
for the dissemination of the viral particles (Roulston et al., 1999). Previous reports 
have suggested the role of apoptosis in the pathogenesis of PCV2, especially 
apoptosis of the lymphocytes and histiocytes (Kiupel et al., 2001, Shibahara et al., 
2000). However, other reports have argued against the role of apoptosis in the 
development of PMWS and implicate defect in proliferation of lymphocytes and 
defective co-stimulation of lymphocytes (Mandrioli et al., 2004, Resendes et al., 
2004). Our study reported here supports that apoptosis, induced by ORF3, plays 
an important role in the pathogenesis by PCV2 by using the ORF3 deficient 
PCV2. Our experiments show that the double mutant PCV2 is ameliorated in its 
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pathogenicity in SPF piglets. The viremia in mutant virus inoculated group 1 
piglets was lower when compared with wildtype virus inoculated group 2 piglets 
on any day after inoculation (Fig. 11). The viremia of the group 1 was transient 
and rapidly declined when compared with the protracted viremia in group 2 
piglets. The transient viremia of the virus in group 1 on comparison with group 2 
is indicative of a better immune response. The wildtype PCV2 inoculated group 2 
piglets showed a decrease in the lymphocyte count, especially IgM positive B 
lymphocytes and CD4 positive T lymphocytes when compared to the group 1 
piglets (Figs. 12A, B). Further, the variations in lymphocyte counts among the 
group 2 piglets were higher than the group 1 piglets. These were indicative of 
perturbations in the lymphoid cells in the group 2 piglets. This was further 
supported by the histological examination of the lymph nodes from group 2 
piglets, which showed loss of follicular areas and normal architecture. The group 
1 piglets had an intact architecture of the lymph nodes, which was indicative of 
absence of pathogenesis mediated by PCV2. The absence of any clinical disease 
in the group 1 piglets was further evident on the histological examination of the 
organs of the piglets. On the contrary, the group 2 piglets showed histological 
lesions of the parenchymatous organs and lymphnodes characteristic of PCV2 
induced pathology. The PCV2 antigen level seen by immunohistochemistry was 
also significantly more in the lymphnodes of the group 2 piglets compared with 
the group 1 piglets (Figs. 11A, B). Further, the group 1 piglets developed a higher 
peak antibody when compared to the peak level in group 2 piglets (Fig. 10). Also 
the antibody levels declined faster in the group 2 compared with group 1. 
Remarkably, the individual group 2 piglets showed a higher variability in their 
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PCV2 specific IgG response. The ability of the double mutant PCV2, lacking 
ORF3, to produce a better immune response in the group 1 piglets could be due to 
two reasons, the first being the absence of the B-lymphocyte and CD4 T-
lymphocyte downshift and second, the lack of lymphoid depletion of lymph nodes 
(Fig. 14A) which indicate an unimpaired immune system. These observations are 
important considering the fact that lymphocyte depletion and loss of lymphoid 
organ architecture being the most consistent features of PCV2 induced disease 
conditions. Previous observations indicate that lymphocyte depletion in the PCV2 
infection leads to an impaired immune response (Darwich et al., 2002, 2004; 
Shibahara et al., 2000) and a high level of viremia is associated with the 
development of disease in natural infections of PCV2 in pigs (Brunborg et al., 
2004). The uncompromised immune system and low levels of the pathogen reflect 
on the systemic clearance of virus in the group 1 piglets (Fig. 11). Taken together, 
all these observations show the attenuation of pathogenicity of the ORF3 mutant 
PCV2 virus in the inoculated piglets. The role of ORF3 in the pathogenesis of 
PCV2 in vivo in piglets needs to studied further. Purified primary cell populations 
of piglets need to be analyzed to understand the effect of the ORF3 on their 
viability and functionality. 
Characterization of viral virulence factors have been performed by 
mutating the candidate virulence genes in many instances. Influenza A virus NS1 
protein has been truncated to produce an attenuated virus (Cauthen et al., 2007). 
The NS1 truncated mutant of the Influenza A virus has an ameliorated 
pathogenicity in chicken. Similarly, genetically engineered live viruses with 
modified virulence genes have been characterized in important pathogens like 
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Foot and Mouth Disease virus, pseudorabies virus, infectious bursal disease virus, 
etc., to name a few (Mason et al., 1997; Schwartz et al., 2006; Yao et al., 1998). 
These studies have highlighted the role of the virulence genes in the pathogenicity 
of the pathogens. The ORF3 of PCV2 is a nonstructural protein, implicated in 
causing apoptosis in infected cells. This study highlights the role of ORF3 in the 
pathogenesis of PCV2. Other researchers have also brought out experimental and 
epizootiological evidence for the role of ORF3 in the pathogenesis by PCV2. 
Stevenson et al., 2007, have outlined the immunodominant T cell epitopes of 
PCV2 and showed that the ORF3 peptide spanning 31–50 aminoacids is an 
important T cell epitope. The ORF3 peptide fragment 31–50 stimulates a 
proliferative response in T lymphocytes obtained from pigs naturally infected with 
PCV2 (Stevenson et al., 2007). Another series of studies have been performed 
with a chimeric PCV1–2 virus which has the ORF2 of the PCV2 and remaining 
genome from the PCV1 virus (Fenaux et al., 2003, 2004). The immunogenicity 
and pathogenicity of the chimeric virus was studied using an infectious DNA 
clone of this chimeric virus and the live chimeric virus. The chimeric virus was 
reported to be attenuated in its pathogenicity (Fenaux et al., 2003, 2004). On 
retrospective analysis of this experiment, in the light of ORF3 knock out study 
reported here, the PCV1–2 chimeric virus studies also support the fact that the 
principal virulence factor for PCV2 maps to the ORF1 region of the genome. The 
ORF3 is nested on the complementary strand of ORF1. The genomic region of 
PCV1 corresponding to the ORF3 of PCV2 shows only 61.5% amino acid 
identity. It is an interesting fact that PCV1 is the only nonpathogenic virus in the 
Circoviridae family and is also ubiquitous in its distribution. Further, Timmusk et 
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al., 2008, have reported a phylogenetic analysis of PCV2 genomes, isolated from 
Sweden over the past ten years, grouped in to three categories based on the 
occurrence of PMWS in the farms from which the viruses were isolated; no 
occurrence, new sporadic occurrence and endemic in occurrence. Their analysis 
shows that the ORF3 amino acid sequence variations were found between the 
three categories. Three of the six variations found, were within the first 50 amino 
acids of ORF3. This observation again highlights the role of ORF3 in the 
pathogenesis of PCV2 leading to PMWS. Further, another recent report has also 
specifically highlighted the role of ORF3 in pathogenesis, by showing that ORF3 
expression in mice using a plasmid vector is pathogenic and lethal (An et al., 
2008). The ORF3 induced a lethal increase in the systemic TNFα level. All the 
above observations directly or indirectly point to the role of ORF3 in the 
pathogenesis of PCV2. Our experiments highlight the inciting role of ORF3 in the 
pathogenesis of PCV2. This is the first study demonstrating the importance of 
ORF3 in the pathogenesis of PCV2 in its natural host, the piglets. Further studies 
need to be performed with ORF3 deficient PCV2 virus to understand the 
development of PCV2 associated pathology, especially the effect of the ORF3 
mutant PCV2 on different cellular and tissue compartments in the piglets 
compared to the wildtype PCV2. This will enable the understanding of the 









Porcine circovirus type 2 ORF3 protein competes with P53 in binding to 






















Porcine circovirus 2 (PCV2) belongs to the Circoviridae family along with 
other circoviruses of animals and birds. Although controversial, PCV2 is believed 
to cause immunosuppression by inducing apoptosis in lymphocytes (Kiupel et al., 
2005; Mandrioli et al., 2004; Resendes et al., 2004; Shibahara et al., 2000). In the 
previous chapter the role of the PCV2 encoded ORF3 protein in the pathogenicity 
of the virus during infection of it natural host, the piglets, was described. A novel 
protein encoded by open reading frame 3 (ORF3) in the PCV2 genome was 
identified to induce apoptosis in infected cells (Liu et al., 2005) and play an 
important role in viral pathogenesis in a mice model (Liu et al., 2006). 
Experimental and epidemiological evidence indicates that PCV2-induced 
apoptosis in infected cells in pigs contributes to the pathogenicity of the virus (An 
et al., 2008; Fenaux et al., 2003; Karuppannan et al., 2009; Timmusk et al., 2008). 
Experimental inoculation of piglets with a mutant PCV2 virus deficient in ORF3 
protein expression, discussed in the previous chapter, (Karuppannan et al., 2009) 
is not pathogenic. Similarly, a chimeric PCV2 virus with the ORF2 genomic 
region of PCV2 and the ORF1 genomic region from PCV1, along with the nested 
ORF3 (Fenaux et al., 2003) is also non-pathogenic to the inoculated piglets. It 
should be noted that ORF2 and ORF3 of PCV1 and PCV2 are significantly 
dissimilar, whereas the ORF1 of the two virus genotypes is more than 85% 
identical at the amino acid level. Furthermore, the PCV2 ORF3 protein is found to 
specifically and directly interact with porcine p53-induced RING H2 (pPirh2) (Liu 
et al., 2007). Pirh2 is an E3 ubiquitin ligase, a part of the ubiquitn relay system, 
which marks cellular proteins for degradation by the proteasome system. In the 
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ubiquitin mediated protein degradation, a lysine residue in the target protein is 
covalently coupled to either a 76 amino acid protein known as the ubiquitin 
(Ubiquitintion) or a short chain of ubiquitins (Polyubiquitination) via an iso-
peptide bond. This modification is catalyzed by the co-ordinated action of three 
classes of enzymes known as the E1 (Ubiquitin activating enzymes), E2 
(Ubiquitin conjugating enzymes) and E3 (Ubiquitin ligases) which mobilize the 
ubiquitin monomers for marking the target protein. Of these, the E3 ligases 
catalyse the final ligation of ubiquitin to the target protein. Hence, the E3 ligases 
determine the specificity of the substrate being marked for degradation. 
The Pirh2 is an E3 ubiquitin ligase playing an important role in the 
regulation of cellular p53 turnover. The tumor suppressor p53 protein is activated 
and induced by multiple stresses like DNA damage, oncogenic transformation, 
hypoxia, replication stress, etc. (Horn and Vousden, 2007; Kastan, 2007). The 
activated p53 exerts its tumor suppressor function by inhibiting cell cycling or 
promoting apoptosis in abnormal cells (Horn and Vousden, 2007; Riley et al., 
2008). The tight regulation of p53 level and its activities, by regulation of its 
transcription, posttranslational modification, protein stability, and subcellular 
localization are crucial for maintaining normal cell growth and preventing 
tumorigenesis (Haupt, 2004; Levine, 1997). The regulation of p53 through post-
translational modifications includes phosphorylation and acetylation (Appella and 
Anderson, 2001; Brooks and Gu, 2003). Regulation of subcellular localization of 
p53 leads to translocation of p53 from cytoplasm to the nucleus where it acts as a 
transcriptional factor (Momand et al., 1992; Oliner et al., 1993; Prives and Hall, 
1999; Qian et al., 2002; Riley et al., 2008). The stability of the p53 is regulated 
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mainly by the ubiquitin–proteasome system (Haupt et al., 1997; Honda et al., 
1997; Kubbutat et al., 1997). Several studies have shown that Mdm2, Pirh2, and 
CopI (Corcoran et al., 2004; Dornan et al., 2004; Fang et al., 2000; Honda and 
Yasuda, 2000; Kubbutat et al., 1997) are the important E3 ubiquitin ligases 
regulating p53. Among them, Pirh2 (also known as Rchy1) interacts physically 
with the tumor suppressor p53, at a distinct site, and promotes polyubiquitination 
of p53 and mediates the cytoplasmic proteasomal degradation of p53 (Leng et al., 
2003). Pirh2 is itself a p53-inducible gene product and the expression of Pirh2 is 
tightly regulated by the p53-Pirh2 autoregulatory feedback loop, which also 
facilitates the tight regulation of p53 stability and tumor suppression (Leng et al., 
2003). The structure of Pirh2 and the structural basis of its interaction with p53 
have been recently elucidated, showing that Pirh2 preferentially ubiquitinates the 
transcriptionally active form of p53 (Sheng et al., 2008). Furthermore, the Pirh2 
protein is believed to have its three domains, the N-terminal domain, the RING 
domain, and the C-terminal domain, all of which fold correctly independent of 
each other, arranged in modular fashion and they do not interact with each other 
(Sheng et al., 2008). The interaction between PCV2 ORF3 protein and pPirh2 has 
been shown to be critical in the molecular pathogenesis of PCV2 (Karuppannan et 
al., 2009; Liu et al., 2005, 2006, 2007). Perhaps the modular nature of Pirh2 
permits its interaction with PCV2 ORF3. Measles virus has also been shown to 
manipulate the subcellular localization of human Pirh2 (hPirh2) by redistributing 
the protein to cytoplasm and affecting the stability of hPirh2 (Chen et al., 2005). 
This chapter describes the analysis of the molecular nature of the interaction of 
ORF3 protein and p53 with pPirh2, in vitro and in vivo. We have mapped the 
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minimal interaction domain, comprising of amino acid residues 20 to 65 in the 
ORF3 protein, as essential in competitive interaction between ORF3 protein and 
p53 in binding to pPirh2 and contributing to p53 deregulation. This specific 
interaction plays an important role in virus-induced apoptosis of the infected cells 





















3.2 Materials and methods 
3.2.1 Cell culture and transient transfections 
The PK-15 cells are of porcine origin and free of PCV1 contamination 
(Liu et al., 2005). The cells were maintained in minimal essential medium 
supplemented with 5% heat-inactivated fetal bovine serum (FBS), 5% L-
glutamine, 100 U/ml of penicillin G, and 100 µl/ml streptomycin at 37 °C in a 
humidified 5% CO2 incubator. The H1299 cells of human origin lack endogenous 
p53 expression (ATCC CRL 5803). The H1299 cells were maintained in RPMI 
1640 media supplemented with 5% heat-inactivated fetal bovine serum (FBS), 
100 U/ml of penicillin G, and 100 µl/ml streptomycin at 37 °C in a humidified 5% 
CO2 incubator. All transient transfections were performed using Transfectin 
reagent (Biorad). 
3.2.2 Plasmids and recombinant proteins 
The recombinant protein expression plasmids encoding recombinant 
proteins MBP-p53, MBP-ORF3 were made by cloning the fulllength PCR 
products of p53 and ORF3 genes in pMAL- c4×vector (New England Biolabs). 
MBP-ORF3 deletion expression plasmids were made by cloning the deletion 
constructs of ORF3 (Fig. 19A), made by PCR assembly, in the pMAL-c4X vector. 
The primers used for making the ORF3 deletion constructs are available upon 
request. The expression plasmids were transformed into Escherichia coli K12 TB1 
cells for the expression of the proteins. The MBP-tagged proteins were purified by 
affinity chromatography with amylose resin (New England Biolabs) packed 
columns according to the manufacturer's instructions. The GST-Pirh2 recombinant 
protein expression plasmid was made by cloning the full-length pPirh2 in the 
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pGEX 4T1 vector (GE Life Sciences) and the expression plasmid was transformed 
into E. coli BL21 cells. The recombinant protein was purified by affinity 
chromatography using GSTrap FF Columns (GE Life Sciences). 
The eukaryotic expression plasmids for p53-GFP and ORF3-GFP were 
constructed by cloning the full-length PCR products in pEGFP N1 vector 
(Clontech). ORF3-GFP deletion eukaryotic expression plasmids were made by 
cloning the deletion constructs of ORF3 (Fig. 19A), made by PCR assembly, in 
the pEGFP N1 vector. The Myc-Pirh2 was made by cloning full-length pPirh2 in 
the pCMV Myc vector. 
3.2.3 Binding assays 
The in vitro binding assay was adapted from Leng et al. (2003). Briefly, 
glutathione beads alone, as negative control, or glutathione beads coated with 10 
µg of GST-Pirh2 in binding buffer (100mM NaCl, 20 mM Tris–HCl [pH 8.0], 
0.5% NP-40, 1 mM EDTA, 1 mM EGTA) were incubated, in separate reactions, 
with a constant amount of MBP-p53 (10 µg) in combination with increasing 
amounts (0–25 µg) of MBP-ORF3 or deletion constructs of MBP-ORF3, 
overnight at 4 °C. The glutathione beads were then pelleted down and proteins 
bound to the beads were subsequently washed four times with the binding buffer. 
Proteins bound to the glutathione beads were eluted with SDS sample buffer and 
subjected to 12% SDS–polyacrylamide gel electrophoresis (PAGE) followed by 
electro-transfer to a nitrocellulose membrane. Two micrograms of total protein 
was loaded in each lane. The blot was incubated with a rabbit anti-MBP antibody 
(Clontech, 1:10,000) or a polyclonal guinea pig anti-p53 antibody (1:500) or an 
anti-ORF3 polyclonal-antibody (1:1000) or a goat anti-GST antibody (Clontech, 
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1:500), and then incubated with the appropriate secondary antibody coupled with 
horseradish peroxidase, namely goat anti-rabbit IgG (1:2000; Amersham) or rabbit 
anti-guinea pig IgG (1:2000; Amersham) or rabbit anti-mouse IgG (1:2000; 
Amersham) or rabbit antigoat IgG (1:2000; Amersham) and visualized with the 
ECL plus detection system (Amersham) or Supersignal chemiluminescence 
system (Pierce). Appropriate control experiments were performed with MBP and 
GST proteins, without any fusion proteins attached, to rule out non-specific 
interaction of MBP with Pirh2 and GST with ORF3 or p53 (data not shown). 
3.2.4 Co-immunoprecipitation assays 
H1299 cells were cotransfected with the expression plasmids for ORF3-
GFP, p53-GFP, and Myc-Pirh2. At 36 h post-transfection, cell extracts were 
prepared and used for co-immunoprecipitation assay either using a commercial kit 
according to the manufacturer's protocol (Profound Myc CoIP kit, Pierce) or using 
polyclonal antip53 and polyclonal anti-ORF3 antibodies followed by the pull 
down of the antibody antigen complex using protein A sepharose beads (Sigma). 
Briefly, 100 µl of M-PER lysis buffer (Pierce) supplemented with Complete mini 
protease inhibitor (Roche) and 1 mM of sodium orthovanadate was used to 
prepare the cell extract from one 35-mmdiameter cell culture dish, transfected 
with the appropriate plasmids. Lysates from three dishes were pooled and 300 µl 
of the lysate was used for the immunoprecipitation. The precipitated proteins were 
eluted with 30 µl elution buffer. The lysates and the immunopreci-pitates were 
analyzed by Western blot against the common GFP epitope tag using a 
monoclonal anti GFP antibody. The blots were also probed with anti-Myc 
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monoclonal antibody, anti-p53 polyclonal antibodies, and anti-ORF3 polyclonal 
antibodies. 
3.2.5 Immunofluorescence assays 
H1299 cells seeded on a coverslip were cotransfected with the expression 
plasmids for fusion proteins Myc-Pirh2 and ORF3-GFP. At 36 h post-transfection, 
cells were fixed in 4% paraformaldehyde for 30 min and permeabilized with 0.1% 
Triton X-100 for 15 min at room temperature. Cells were incubated with a mouse 
monoclonal anti- Myc antibody (BD Pharmingen), at 37 °C for 1 h. After 
washing, cells were incubated with Alexa 560 coupled anti-mouse 
immunoglobulin secondary antibody (Invitrogen) for 1 h. The cells were then 
washed, mounted with VECTASHIELD mounting medium (Vector), and 
examined with a Zeiss LSM Meta 510 confocal microscope. 
3.2.6 Estimation of protein turnover rates 
The assay to determine the stability of pPirh2 was performed in H1299 
cells in 35-mm-diameter plates transfected with 100 ng Myc- Pirh2 expression 
plasmid alone or in combination with 100 ng of ORF3-GFP expression plasmid. 
Twenty-four hours after transfection, cells were treated with 50 µg/ml of 
cycloheximide (Calbiochem) for different lengths of time before the cells were 
lysed with M-PER cell lysis buffer (Pierce) supplemented with complete mini 
protease inhibitor cocktail (Pierce) and 1 mM of sodium orthovanadate. Cell 
lysates were analyzed by immunoblotting with anti-Myc antibody followed by 
HRP-conjugated anti-mouse secondary antibody to detect Pirh2 levels. 
Immunoblotting with anti-GFP antibody was performed as a loading control. The 
protein levels were quantified by immunoblotting with anti-Myc antibody or anti-
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actin antibody followed by an infrared dye (IR680)-conjugated secondary 
antibody (Li-Cor). The protein band intensities were measured by Li-Cor Odyssey 
infrared scanner. The Myc-Pirh2 protein levels were normalized with reference to 
actin levels in the lysate and are expressed as a percent of the initial level of Myc-
Pirh2 protein before cycloheximide treatment. 
3.2.7 MTT assay for cell viability 
For measuring the cell viability after ORF3 protein expression, PK- 15 
cells or H1299 cells were cultured in 96-well plates at a density of 1×104 
cells/well and transfected with the pEGFP N1 vector or pEGFP N1 vector 
containing the full-length or deletion constructs of the ORF3. Thirty-six hours 
after the transfection, the cultures were incubated with 0.5 mg/ml MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide tetrazole) solution for 4 h 
at 37 °C then solubilized in 150 µl dimethyl sulfoxide (DMSO). Nontransfected 
cells were used as the baseline for the viability of the cells. The viable cells 
convert the MTT into purple-colored insoluble formazan, which is solubilized by 
DMSO. The optical density of the samples was measured at 490 nm and data 
expressed as mean percentage of cell survival in two individual experiments 
performed in triplicates. 
3.2.8 Flowcytometry 
For measuring the apoptotic cells after ORF3 protein expression, PK-15 
cells were cultured in 60-mm tissue culture dishes and transfected with the pEGFP 
N1 vector or pEGFP N1 vector containing the full-length or deletion constructs of 
the ORF3. Thirty six hours after the transfection, floating and trypsin-detached 
cells were pooled and washed twice with ice-cold PBS and fixed in 70% cold 
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ethanol and then washed twice in PBS. After centrifugation, the cell pellets were 
stained with PBS–propidium iodide (50 µg/ml) and RNase A (100 µg/ml) for 45 
min. DNA content of PK-15 cells was analyzed by fluorescence-activated cell 
sorting (FACS Calibur; Becton Dickinson). At least 10,000 events were analyzed, 
and the percentage of cell in the sub-G0/G1 population was calculated. 
Aggregates of cell debris at the origin of the FSC/SSC histogram were excluded 
from the analysis of sub-G0/G1 cells. In each experiment, mock-infected PK-15 
cells were used as controls and compared with transfected cells. 
3.2.9 In vitro ubiquitination assay 
Ubiquitination assays were carried out by adding MBP-Pirh2 (1 µg), rabbit 
E1 (100 ng, Calbiochem), UbcH5b (E2) (200 ng, Calbiochem), His-tagged 
ubiquitin (4 µg), GST-p53 (1 µg), MBP-ORF3 (1 µg), and 10 µl of BL-21 
bacterial lysate in ubiquitination buffer (50 mM Tris–HCl [pH 7.4], 2 mM ATP, 5 
mM MgCl, 2 mM DTT, 30 mM creatine phosphate, and 0.05 mg/ml creatine 
phosphokinase) to a final volume of 150 µl. The reactions were incubated at 30 °C 
for 2 h. At the end of the incubation, the volume was made up to 1 ml and the 
GST-p53 was pulled down using glutathione-sepharose beads (GE Amersham). 
The beads were then boiled in SDS loading buffer at 95 °C for 5 min, and the 
supernatant was analyzed by Western blotting and probing with anti-His 







3.3.1 The ORF3 protein prevents p53 from binding pPirh2 in vitro and in 
vivo.  
The binding of ORF3 protein to the p53 interacting domain of pPirh2 was 
previously identified by a yeast two-hybrid screen (Liu et al., 2007). Further yeast 
two-hybrid experiments with mutated ORF3 protein and the full-length pPirh2 
identified the amino acid residues 20 to 75 of ORF3 protein to be necessary for 
the interaction between the two proteins (Karuppannan et al., 2009). To further 
characterize the nature and effect of this interaction, a competitive pull down 
assay was carried out using purified recombinant proteins. Briefly, 10 µg of GST-
Pirh2 was incubated with a constant amount of MBP-p53 (10 µg) and increasing 
amounts of MBP-ORF3 (0-25 µg). The GST-Pirh2 was then pulled down and the 
bound MBP-tagged p53 and ORF3 were visualized by Western blotting. As 
shown in Fig. 15, the amount of p53 bound to GST-Pirh2 decreased with an 
increase in the amount of ORF3 protein in the mixture, indicating that the ORF3 
protein prevents p53 from binding to pPirh2 in vitro. At equal protein 
concentrations of ORF3 and p53, more ORF3 bound to the pPirh2. To further 
determine the relative binding capacities of pPirh2 to ORF3 protein and p53 in 
vivo, H1299 cells, which do not express p53, were co-transfected with the 
expression plasmids for ORF3-GFP, p53- GFP, and Myc-Pirh2. The transfected 
cells were lysed 36 h post transfection and co-immunoprecipitation assay was 
performed with anti-myc antibody. Western blotting against the common GFP 
epitope tag was performed to compare the expression levels of ORF3 protein and 
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p53 in the lysates and to estimate the comparative amount of protein co-
immunoprecipitating with pPirh2.  
When ORF3-GFP and p53-GFP were expressed at similar levels, Myc-
Pirh2 co-precipitated significantly more ORF3 protein than p53 (Fig. 16A). 
However, when only p53-GFP and Myc-Pirh2 expression plasmids were 
transfected in H1299 cells, the amount of p53-GFP co-precipitating with Myc-
Pirh2 was higher than in the presence of ORF3 protein (Fig. 16A) and was 
comparable to the level of expression in the lysate (Fig. 16B). To further confirm 
the observations, reciprocal co-immunoprecipitation experiments were performed 
with anti-ORF3 and anti-p53 polyclonal antibodies. Similar amounts of ORF3-
GFP and p53-GFP were pulled down by the respective polyclonal antibodies, 
whereas the anti-ORF3 antibodies co-precipitated more Myc-Pirh2 than anti-p53 
antibodies (Fig. 16C). This shows that ORF3 competes with p53 in binding to 
pPirh2, when expressed at similar levels. Taken together the pull down assay and 
the immunoprecipitation assays suggest that ORF3 protein competes with p53 in 












Figure 15. The ORF3 protein directly binds to pPirh2 and prevents p53 from 
binding to pPirh2 in vitro. Glutathione beads coated with 10 µg of GST-Pirh2 
were incubated with a constant amount of MBP-tagged p53 (10 µg) and increasing 
amounts of MBP-tagged ORF3 (0, 5, 10, 15, 20, and 25 µg in lanes 1 to 6, 
respectively). Lane 7 is a control without MBP-p53 and 5 µg of MBP-ORF3. 
After washing the beads, MBP-tagged proteins bound to the beads were detected 




















Figure 16. Relative affinity of interaction of pPirh2 to p53 and ORF3 protein (in 
vivo). (A) H1299 cells were transfected with Myc-Pirh2 and p53-GFP in the 
presence or absence of ORF3-GFP. Anti- Myc immunoprecipitate was blotted 
with anti-GFP antibody to detect the relative amounts of co-precipitated ORF3-
GFP and p53-GFP. Comparison of the ratio of ORF3-GFP to p53- GFP in the 
lysate and the immunoprecipitate suggests stronger binding of Pirh2 to ORF3 
protein than p53 (lane 5). Pirh2 co-precipitates more p53 in the absence of ORF3 
protein (lane 3). (B) H1299 cells were transfected with Myc-Pirh2 and p53-GFP 
in the presence or absence of ORF3-GFP. Anti-GFP immunoblot of lysates from 
H1299 cells transfected with the three constructs Myc-Pirh2, p53-GFP, and 
ORF3-GFP, as indicated. (C) ORF3 interferes with the binding of Pirh2 to p53. 
Coimmunoprecipitation experiment was performed by using cell lysate from 
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H1299 cells transfected with expression plasmids for Myc-Pirh2, p53-GFP, and 
ORF3-GFP. Thirty-six hours after transfection, the cell lysate was 
immunoprecipitated with anti-ORF3 polyclonal antibodies and anti-p53 
polyclonal antibodies, in lane 1 and lane 2, respectively, and immunoblotted with 
























3.3.2 ORF3 protein alters the subcellular localization of pPirh2 
In the case of proteins targeted for ubiquitin-dependent degradation, 
subcellular localization is a factor that can regulate protein stability. It has been 
previously demonstrated that Pirh2 subcellular localization could be critical in its 
regulation and stability (Logan et al., 2004). The Pirh2 mediates the 
polyubiquitination of the tetrameric, transcriptionally active, p53 in the nucleus 
and leads to the p53 export to the cytoplasm and subsequent proteasomal 
degradation (Sheng et al., 2008). In an attempt to explain the mechanism by which 
ORF3 protein could interfere with the function of pPirh2 in regulating p53 protein 
stability, the subcellular localization of pPirh2 was examined in the presence of 
ORF3 protein, in H1299 cells. pPirh2 was found in the nucleus after transfection 
in H1299 cells (Fig. 17A). Interestingly, co-transfection of pPirh2 with ORF3 
protein resulted in significant accumulation of pPirh2 in the cytoplasm (Fig. 17B). 
This suggests the inter-action of ORF3 protein, which localizes to the cytoplasm, 
with pPirh2. The above observations suggest that in the presence of ORF3 protein, 
pPirh2 would not be available to down-regulate the p53 levels in the nucleus. 
ORF3 protein increases the turnover of pPirh2. The stability of Pirh2 is affected 
by many proteins (Chen et al., 2005; Duan et al., 2007; Logan et al., 2004; Zheng 









Figure 17. ORF3 protein alters the sub-cellular localization of pPirh2. H1299 cells 
were co-transfected with the expression plasmids for Myc-tagged pPirh2 alone 
(A) or in combination with expression plasmids for GFP-tagged ORF3 (B). At 36 



























Figure 18. ORF3 protein decreases the stability of Pirh2. (A and B) H1299 cells 
were transfected with expression plasmids for Myc-Pirh2 alone (A) or in 
combination with ORF3-GFP (B). The stability of Pirh2 was estimated 24 h post-
transfection by using cycloheximide (50 µg/ml). The cell lysates obtained at 
different time points after cycloheximide treatments were analyzed for Pirh2 
levels by Western blotting. (C) Estimation of Myc-Pirh2 protein levels at different 
time points after cycloheximide treatment in H1299 cells transfected with 
expression plasmids for Myc-Pirh2 alone (solid line) or in combination with 
ORF3-GFP (dotted line). The protein levels were estimated by Western blotting 
with infrared dye (IR 680)-conjugated secondary antibody followed by scanning 
with an infrared scanner. The normalized Myc-Pirh2 protein levels are expressed 







Our previous observations showed a decrease in the level of pPirh2 protein 
during PCV2 infection (Liu et al., 2007). Here, we estimated the turnover of the 
pPirh2 protein in the presence or absence of ORF3 protein, in H1299 cells. 
Expression plasmid encoding Myc-Pirh2 was transfected in H1299 cells, alone or 
in combination with expression plasmid coding for ORF3-GFP and the turnover 
of the pPirh2 was measured using protein synthesis inhibitor cycloheximide. The 
quantities of plasmids used for the transfection were kept minimal to avoid 
competition between the two proteins for the transcription and translation 
apparatus of the transfected cells. The result showed that pPirh2, when 
overexpressed alone, was detectable for about 5 h after cycloheximide treatment 
(Fig. 18A). However, the pPirh2 expressed with ORF3 protein was not detectable 
after 2 h of cycloheximide treatment (Fig. 18B). In order to quantify the levels of 
pPirh2 after cycloheximide treatment, Western blotting was performed followed 
by protein visualization and quantification with infrared dye-conjugated secondary 
antibody using a sensitive infrared scanner. The pPirh2 levels, at 2 h after 
cycloheximide treatment, were twofold less in the presence of ORF3 compared to 
the pPirh2 alone (Fig. 18C). The results again indicated that the ORF3 protein 







3.3.3 Mapping of the minimal domain of ORF3 protein that binds with 
pPirh2 
To identify the regions on ORF3 protein involved in interaction with 
pPirh2, eukaryotic expression plasmids of full-length ORF3 protein tagged with 
GFP or its deletion mutants (Fig. 19A) were transfected into PK-15 cells. A MTT 
(3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide, a tetrazole) assay 
was performed to measure the relative numbers of viable cells at 36 h after 
transfection of wild-type ORF3 and the mutant ORF3 constructs in PK-15 cells. In 
this assay MTT is reduced to purple formazan by enzymes in the living cells. The 
results showed that PK-15 cells transfected with ORF3-20–50 GFP and ORF3-
35–65 GFP showed significantly more number of viable cells compared with cells 
transfected with wild-type ORF3 and other mutants (Fig. 19B). We assumed that 
the ORF3 deletion mutants 20–50 and 35–65 induce fewer cells to become 
apoptotic than that of wild-type ORF3 or other ORF3 deletion mutants owing to 
their loss of the ability to interact with pPirh2. To confirm this, the level of 
apoptosis in the PK-15 cells transfected with different deletion construct of ORF3 
was analyzed by flow cytometry. The results (Fig. 19C) showed that the ORF3 
deletion mutants 20–50 and 35–65 did not induce apoptosis in the transfected cells 
and were comparable to the vector control expressing GFP only. Interestingly, 
when H1299 cells, lacking endogenous p53, were transfected with the different 
constructs of ORF3, the viability of the cells was not reduced to the extent 
observed in similarly transfected PK-15 cells (Fig. 19B) and further there was no 










Figure 19. (A) Schematic diagram of ORF3 protein and its deletion mutants. (B) 
ORF3 protein and its deletion mutants differ in their ability to induce loss of cell 
viability. PK-15 cells and H1299 were transfected with ORF3-GFP or its deletion 
mutants and after 36 h the viability of the cells was measured by MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide tetrazole) assay. Cells 
transfected with GFP expression plasmids carrying no inserts were used as a 
control and non-transfectd PK-15 cells or H1299 cells were treated as 100% 
viable cells. (C) PK-15 cells and H1299 were transfected with ORF3-GFP or its 
deletion mutants, and after 36 h, the level of apoptotic cells was measured by 
flowcytometric analysis. At least 10,000 events were acquired and the percent of 








































Figure 20. (A) Interaction between the ORF3 protein and its deletion mutants with 
Pirh2 in vitro. MBP, MBP-ORF3, or its deletion mutants were incubated with 
glutathione beads coated with GST-Pirh2, and after extensive washing, the 
proteins bound to the beads were analyzed using immunoblotting with an anti-
MBP antibody or GST antibody. (Lane 1, MBP; 2, MBP-ORF3; 3, MBP-ORF3-
20; 4, MBP-ORF3-20-50; 5, MBP-ORF3-35-65; 6, MBP-ORF3-50-80; 7, MBP-
ORF3-65-95; 6, MBP-ORF3-80). (B) ORF3 with deletion in the minimal binding 
sequence does not hinder the interaction between Pirh2 and p53. H1299 cells were 
transfected with Myc-Pirh2 and p53-GFP in the presence of ORF3-GFP harboring 
a deletion of amino acids 30–60. The total lysate and Myc-Pirh2 
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immunoprecipitate from the lysate were analyzed by immunoblotting with anti-
GFP antibody to detect the relative amounts of co-precipitated ORF3-GFP and 
p53-GFP. (C) ORF3 with deletion in its minimal binding sequence does not alter 
the subcellular localization of Pirh2. H1299 cells were cotransfected with the 
expression plasmids for Myc-Pirh2 in combination with expression plasmid for 
ORF3-GFP with a deletion of amino acids 30–60. At 36 h post-transfection, cells 
were fixed and immunostained with an anti-Myc antibody. (D) ORF3 protein with 
deletion in its minimal binding sequence does not alter the stability of Pirh2. 
H1299 cells were transfected with expression plasmids for Myc-Pirh2 in 
combination with ORF3-GFP harboring a deletion of amino acids 30–60. The 
stability of Pirh2 was estimated 24 h post-transfection by using cycloheximide (50 
µg/ml). The cell lysates obtained at different time points after cycloheximide 
treatment were analyzed for Pirh2 levels by Western blotting. (E) Estimation of 
Myc-Pirh2 protein levels at different time points after cycloheximide treatment in 
H1299 cells transfected with expression plasmids for Myc-Pirh2 and ORF3-GFP 
harboring a deletion of amino acids 30–60. The protein levels were estimated by 
Western blotting with anti-GFP or anti-actin primary antibodies followed by 
infrared dye (IR 680)-conjugated secondary antibody and subsequent scanning by 
an infrared scanner. The normalized Myc-Pirh2 protein levels are expressed as a 















To further investigate the interaction between ORF3 mutants and pPirh2, 
an in vitro pull down assay was carried out using purified recombinant MBP-
tagged ORF3 or MBP-tagged ORF3 deletion mutants. MBP-tagged ORF3 protein 
or MBP-tagged ORF3 deletion mutants were incubated with glutathione beads 
coated with GSTPirh2 in an in vitro binding assay. After extensive washing, the 
protein bound to beads was analyzed by immunoblotting with an anti-MBP 
antibody or anti-GST antibody (Fig. 20A). The results further demonstrated that 
the ORF3 protein with deletions in the amino acid residues 20–50 and 35–65 does 
not interact with pPirh2 as efficiently as wild-type ORF3 protein or other ORF3 
deletion mutants, which suggested that the region containing the 20th to 65th 
amino acid residues could be important in the interaction between pPirh2 and p53. 
For further confirmation of the lack of interaction, co-immunoprecipitation studies 
were performed in H1299 cells cotransfected with Myc-Pirh2, p53-GFP, and 
ORF3-GFP with deletion of amino acids 30 to 60. The Myc-Pirh2 co-
immunoprecipitated p53-GFP but did not co-immunoprecipitate the ORF3-GFP 
deletion mutant (Fig. 20B), showing that the deleted regions were necessary for 
the interaction between pPirh2 and ORF3. We next examined if the lack of 
interaction between the ORF3 30-60 and pPirh2 had any effect on the localization 
and stability of pPirh2. Immunofluorescence assay revealed that the ORF3 
deletion mutant 30–60 did not alter the localization of the pPirh2 from the nucleus 
to the cytoplasm (Fig. 20C). In addition, the turnover of the pPirh2 co-expressed 
with ORF3 deletion mutant 30– 60 (Figs. 20D and E), in H1299 cells, were 
similar to that of pPirh2 expressed in the absence of ORF3. These results 
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illuminated the fact that an interaction between ORF3 and pPirh2 is necessary for 
the altered cellular fate of pPirh2. 
3.3.4 Interaction of ORF3 protein with pPirh2 up-regulates cellular p53 
levels 
The observation of interaction between the ORF3 protein or its deletion 
mutants and pPirh2 prompted an examination to determine whether the ORF3 
deletion mutation proteins affected the p53 level and its apoptosis-inducing 
function. Since the ORF3 deletion mutants 20–50 and 35–65 cannot induce 
apoptosis in cells markedly as shown above (Fig. 19B), these two deletion mutants 
probably have no effect on the expression of p53 as compared with wild-type 
ORF3 or other ORF3 deletion mutants. The expression of p53 in PK-15 cells 
transfected with ORF3-GFP or ORF3-GFP deletion mutant expression constructs 
was analyzed by a Western blotting assay. The results showed that p53 was 
expressed in higher level after transfection with different ORF3 constructs 
compared with normal PK-15 cells, but p53 expression in cells transfected with 
ORF3-20–50 GFP and ORF3-35–65 GFP were less than that of ORF3 full-length 
construct or other deletion mutants (Fig. 21). These results illuminated that ORF3 
20–50 and 35– 65 deletion mutants do not significantly affect the expression level 









Figure 21. Detection of endogenous p53 after transfection with ORF3-GFP and its 
deletion mutants in PK-15 cells. The expression of p53 was estimated, 24 h after 
transfection with ORF3 or its deletion mutants, by Western blotting assay for 
detecting the levels of p53 by using guinea pig anti-p53 antibody. Anti-actin 































3.3.5 ORF3 interferes with the in vitro ubiquitination of p53 
The interaction of ORF3 with Pirh2 could potentially interfere with the E3 
ubiquitin ligase function of Pirh2. To examine this, an in vitro ubiquitination assay 
was performed. The assay was performed with Pirh2 as an E3 ubiquitin ligase, 
GST-p53 as the target protein, Histagged ubiquitin, and E1 and E2 ubiquitin 
ligases as described in the methods. The GST-p53 was pulled down at the end of 
the assay and analyzed by Western blotting. The His-tagged ubiquitin was 
covalently conjugated to p53 in the absence of ORF3 (Fig. 22). However, in the 
presence of ORF3, the ubiquitination of p53 was almost completely inhibited. The 
results of this in vitro ubiquitination assay indicate that ORF3 interferes with the 
ubiquitination of p53 by Pirh2. This inhibition of ubiquitination of p53 by ORF3 
















Figure 22. In vitro assay for ubiquitination of p53. The in vitro ubiquitination of 
GST-p53 was analyzed in the presence or absence of ORF3, with Pirh2 as the E3 
ubiquitin ligase and His-tagged ubiquitin. The GST-p53 was purified with 












The role of ORF3 protein in the induction of apoptosis in PCV2- infected 
cells has been previously demonstrated (Liu et al., 2005). Furthermore, the ORF3 
protein is important in determining the pathogenicity of the PCV2 at the 
organismal level in mice and piglets (An et al., 2008; Fenaux et al., 2003; 
Karuppannan et al., 2009; Liu et al., 2006). An et al., 2008, have highlighted the 
pathogenic role of ORF3 by overexpressing the protein in mice, leading to severe 
inflammatory reactions or mortality. Here we show that PCV2 ORF3 protein and 
p53 competitively interact with pPirh2 and that the ORF3 protein is able to 
prevent the interaction between pPirh2 and p53 (Figs. 15 and 16) both in vitro and 
in vivo. In addition, our data strongly reveals that the fragment comprising the 
amino acid residues from 20 to 65 residues of the ORF3 protein is essential (Figs. 
19–21) in the competitive binding of ORF3 protein to pPirh2 over p53. The 
interaction of ORF3 to pPirh2, sequesters pPirh2 in the cytoplasm (Fig. 17), and 
prevents its physiological localization to the nucleus, where it functions to 
polyubiquitinate p53, leading to its cytoplasmic export and degradation. The 
interaction of pPirh2 to ORF3 protein further leads to the decreased stability of the 
pPirh2 (Fig. 18). Thus the sequestration and destabilization of pPirh2 by ORF3 
protein lead to the increase in cellular p53 levels (Fig. 21), leading to apoptosis of 
the cells. Furthermore, the ORF3 interferes with the E3 ubiquitin ligase function 
of Pirh2 to ubiquitinate p53 in an in vitro ubiquitination assay (Fig. 22). This 
indicates that the interaction of ORF3 and Pirh2 leads to the deregulation of the 
p53 degradation and its stabilization. The effect of the interaction between ORF3 
and pPirh2 is reiterated by the lack of altered localization or increased turnover of 
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the pPirh2 by the ORF3 mutant 30–60, lacking the minimal interaction domain 
(Figs. 20C, D, and E). 
Together with the results obtained by Liu et al. (2007), the data presented 
here suggest that ORF3 protein increases cellular p53 level and favors the 
induction of apoptosis by competitive binding to pPirh2, over p53, and the 
cytoplasmic sequestration of pPirh2. First, the competitive binding of ORF3 
protein to pPirh2 could abrogate the E3 ubiquitin ligase function of pPirh2 on p53 
and indirectly lead to the accumulation of p53 (Figs. 21 and 22). The cellular 
accumulation of Pirh2 regulated proteins, in the absence of Pirh2, has been 
previously observed (Hattori et al., 2007). The pPirh2-mediated increase in p53 
protein can lead to the increased accumulation of p53 in the nucleus and the 
increased transcriptional activity mediated by p53 and the increased cellular 
susceptibility to apoptosis. Second, ORF3 protein could induce post-translational 
modifications of pPirh2, which may further cause conformational changes that 
make pPirh2 less functional or more susceptible to degradation. Our observations 
here show that the stability of pPirh2 is significantly reduced in the presence of 
ORF3 protein. This observation is in concurrence with our previous observation 
that pPirh2 is reduced in PCV2-infected cells (Liu et al., 2007). Studies on the 
physiological regulation of Pirh2 are few. The CaMII kinase (calmodulin-
dependent kinase II) phosphorylates Pirh2 and the phosphorylation of Pirh2 
impairs its p53 E3 ubiquitin ligase function (Duan et al., 2007). Furthermore, the 
phosphorylation of Pirh2 impairs its stability (Duan et al., 2007). Various cellular 
factors like TIP60, PLAGL2 are also known to increase the stability of Pirh2 
(Logan et al., 2004; Zheng et al., 2007). The degradation of hPirh2 is thought to 
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depend on its polyubiquitination and also on the presence of an intact RING 
domain (Logan et al., 2004). A histone acetylase TIP60, by its interaction, is able 
to stabilize polyubiquitinated Pirh2. However, the acetylase activity of TIP60 is 
dispensable for this effect and the mechanism of stabilization is unknown. 
Another exogenous protein, the measles virus phosphoprotein (P protein), is 
known to interact with and stabilize the hPirh2 by preventing its ubiquitination 
(Chen et al., 2005). The ORF3 protein negatively affects the pPirh2 stability by a 
yet unknown mechanism. The Pirh2 is also known to regulate the stability of 
many other proteins apart from p53; notable among them are p27kip1, HDAC1, 
epsilon COP, and signal recognition particle subunit beta (Abe et al., 2008; 
Hattori et al., 2007; Logan et al., 2006; Maruyama et al., 2008). The interaction of 
ORF3 protein with pPirh2 could also affect cellular mechanisms other than p53-
regulated cell survival. This was examined in the H1299 cells, which lack 
endogenous p53. Our observations upon over expression of ORF3 protein in 
H1299 cells, lacking p53, indicate (Fig. 19B) that p53-mediated apoptosis is the 
foremost effect of ORF3 protein on the cellular homeostasis. In summary, the data 
presented here demonstrate a link between the competitive interaction of ORF3 
protein with pPirh2 and the regulation of p53-mediated apoptosis, which is one of 
the important molecular mechanisms involved in PCV2 pathogenicity.  
Pirh2 is known to be over expressed in lung cancer cells of humans, mice 
lung cancer models, and prostate cancer in humans (Duan et al., 2004; Logan et 
al., 2006; Sheng et al., 2008). The role of Pirh2 in promoting tumor formation is 
thought to be independent of Mdm2, another important E3 ligase regulating the 
levels of p53 (Duan et al., 2004; Sheng et al., 2008). Targeting the p53-Pirh2 
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interface is an attractive approach to discover agents that activate p53 in tumors. 
In one instance, the targeting of Pirh2 by siRNA along with siRNA targeting the 
oncogenic E6 protein of human papillomavirus, in Hela cervical cancer cells, 
enabled the sustained restoration of activated p53 (Koivusalo et al., 2006). 
Strategies of disruption of the p53–Pirh2 interaction have a novel potential as new 
anticancer agents as the binding sites of Pirh2 and Mdm2 on p53 are distinct 
(Sheng et al., 2008). The ORF3 protein is a naturally evolved molecule (Timmusk 
et al., 2008), which binds to the p53-interacting domain of Pirh2 (Liu et al., 2007). 
The ORF3 efficiently disrupts the p53 homeostasis by interacting with Pirh2, 
through its amino acid residues 20 to 65, and favors apoptosis. Based on our 
results, we speculate that the inhibition of p53–Pirh2 interaction in cells, with 
exogenous ORF3 protein or synthetic peptide molecules of ORF3 protein (such as 
fragment from the 20th to 65th amino acid residues) should lead to both the 
nuclear accumulation and the activation of p53, increasing the propensity of the 
cells towards apoptosis. The ORF3 protein-mediated inhibition of the p53–Pirh2 
interaction might be an attractive new way for an antivirus or anticancer agent that 
could be used to activate wild-type p53 in target cells. Further investigation of the 


































Porcine circovirus 2 (PCV2) is the primary causative factor of post 
weaning multisystemic wasting syndrome (PMWS) in Swine (Allan et al., 1998; 
Ellis et al., 1998). The PCV2 genome encodes for three major open reading 
frames (ORF), which code for the replication associated proteins (ORF1), capsid 
protein (ORF2), and an apoptosis inducing protein (ORF3), which is not essential 
for the replication of the virus (Cheung, 2003; Liu et al., 2005). The study of the 
virus by molecular and epidemiological analysis, by various groups across the 
globe, points out two virus associated factors related to the replication cycle of the 
virus; polymorphisms in the capsid region of the virus and the ORF3 protein, 
which induces apoptosis in virus-infected cells (Cheung et al., 2007; Finsterbusch 
and Mankertz, 2009; Kiupel et al., 2005; Timmusk et al., 2008). The 
polymorphisms in the ORF2 protein could play a role in the cellular entry of the 
virus, which is thought to be mediated by the interaction of the capsid with cell 
surface Heparan Sulphate and Chondroitin Sulphate (Misinzo et al., 2006). 
Alternatively, the ORF2 polymorphisms could also affect the dynamics of virus 
assembly or the structural stability of the virus, which is known to have a high 
degree of thermal stability (O'Dea et al., 2008). Thus polymorphisms of ORF2 
could lend a higher degree of fitness to viruses carrying certain “alleles” of ORF2. 
This is indeed reflected by the widespread geographical distribution of certain 
PCV2 genotypes, based on ORF2, observed in the epizootiological data (Cheung 
et al., 2007; Cortey et al., 2010; Gagnon et al., 2007; Wiederkehr et al., 2009). The 
second factor, the apoptosis induced by the ORF3, causes the loss of lymphocytes 
and lymphoid organ destruction in PCV2-infected piglets (Shibahara et al., 2000; 
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Darwich et al., 2002; Nielsen et al., 2003; Liu et al., 2005, 2006; Timmusk et al., 
2008; Karuppannan et al., 2009). The lymphocytes play a pivotal role in the 
development of the PCV2 infection associated diseases. The development of the 
PMWS is thought to be positively correlated with the proliferation of the 
lymphocytes induced by vaccination or co-infection with other infectious agents 
in the experimental disease models of PMWS (Krakowka et al., 2001, 2007; 
Ladekjaer-Mikkelsen et al., 2002). The replication of PCV2 in the lymphocytes 
eventually leads to their apoptosis. However, infection of mutant PCV2, deficient 
in ORF3, expression does not cause lymphocyte depletion or PCV2 associated 
pathogenesis in experimentally infected piglets, revealed by histological and 
systemic evidence (Karuppannan et al., 2009). The ORF3 of PCV2 interacts with 
Pirh2, an E3 ligase involved in the ubiquitination of p53, resulting in the 
decreased levels of Pirh2 and an increase in levels of p53, and leading to apoptosis 
of the virus-infected cells (Liu et al., 2007; Karuppannan et al., 2010). Our 
previous studies have shown that SPF piglets inoculated with ORF3-deficient 
PCV2 show a delay in the onset of systemic viremia with a decreased level of 
peak viremia compared with the wild-type PCV2 inoculated specific pathogen 
free piglets (Karuppannan et al., 2010). We hypothesize that the apoptosis induced 
by the ORF3 of PCV2 could also have a role in the rapid spread of the virus, 
leading to high viral load, which is associated with the development of PCV2 
associated diseases. Any factor that enhances the spread of the virus could 
increase its evolutionary fitness. Indeed, retrospective epidemiological analyses in 
Sweden have shown that specific ORF3 based phylogroups of PCV2 virus are 
associated with PCV2 induced disease (Timmusk et al., 2008). This chapter 
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describes the role of PCV2 ORF3 in the spread of the virus infection using in vitro 
























4.2 Materials and methods 
4.2.1 Cell culture and viruses 
The PK-15 cells are of porcine origin and free of PCV1 contamination 
(Liu et al., 2005). The cells were maintained in minimal essential medium 
supplemented with 5% heat inactivated fetal bovine serum (FBS), 5% L-
glutamine, 100U/ml of Penicillin G, and 100 µl/ml streptomycin at 37 °C in a 
humidified 5% CO2 incubator. The PCV2 BJW strain virus was used for the 
experiments (Liu et al., 2005). The chimeric PCV1-2 virus was constructed by 
inserting the ORF2 and origin of replication of the PCV1 (DQ472015) in place of 
its PCV2 (BJW strain) counterparts. The viral genome was synthesized from a 
commercial source (Genscript, USA) and the virus regenerated as described 
previously (Liu et al., 2005). The virus infections were performed in parallel 
cultures of PK-15 cells in 35-mm dishes containing 1 ml of cell culture media. 
Briefly, the cells were seeded overnight and infected at a multiplicity of infection 
(MOI) of 0.1 with the indicated virus. At various time points after the infection, 
the virus genomes in the cell culture supernatant or in the attached cells or the 
total virus numbers were quantified as follows. The cell culture supernatants along 
with the floating cells were collected and the viral genome isolated with QIAamp 
DNA kit (Qiagen) according to the manufacturer's instructions. The attached cells 
were harvested separately by scrapping-off with a sterile cell scarper and re-
suspended in 1 ml PBS and the viral genome isolated as mentioned above. 
Alternatively the scraped cells were suspended in the cell culture supernatant and 
the total viral genome in both the cell free and cell associated compartments was 
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isolated. The viral genome copy numbers were enumerated using real-time 
quantitative PCR as described below. 
4.2.2 Quantitative real-time PCR 
Briefly, viral genome was isolated using the QIAamp DNA (QIAGEN) 
and the copy number was estimated by using LightCycler ® real-time PCR 
machine (Roche Applied Sciences) and DyNAmo™ SYBR® Green qPCR Kit 
(Finnzymes). The primers used were specific for ORF2 in the PCV2 genome and 
amplified a 250-bp region. The primers and PCR parameters used were the same 
as described earlier (Liu et al., 2006). 
4.2.3 Plasmids and transfection 
The ORF3 of PCV2 BJW strain was cloned in pcDNA3.1+ expression 
vector at BamHI and XhoI restriction sites. The following primers were used for 
the amplification of the ORF3 gene. ORF3 forward 5′-
CAGAGGATCCATGGTAACCATCCCACCACTTG-3′, ORF3 reverse 5′-
CAGACTCGAGTTACTTATCGAGTGTGGAGCTC-3′. The PK-15 cells were 
transfected with the plasmid by using Transfectin reagent (Biorad). 
4.2.4 Western blot analysis 
The whole-cell lysates from virus-infected or untreated PK15 cells were 
resolved by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) and blotted onto nitrocellulose membranes (Biorad). The 
membranes were blocked for 1 h at room temperature in blocking buffer TBST 
(20 mM Tris–HCl [pH 7.4], 150 mM NaCl, 0.1% Tween 20) containing 5% skim 
milk powder to prevent nonspecific binding and then incubated with mouse 
polyclonal anti-ORF3 antibody (Liu et al., 2005) or anti-ORF2 specific mouse 
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monoclonal antibody (8C2) at room temperature for 1 h. The membranes were 
then washed three times with TBST and incubated for 1 h at room temperature 
with horseradish peroxidase-conjugated anti-mouse secondary antibody (DAKO) 
diluted in blocking buffer (1:2000). After washing the membrane, the proteins 
were visualized using Super Signal West Femto Chemiluminescent substrate 
(Pierce) and Amersham Hyperfilm (GE Amersham). 
4.2.5 Assay for caspase activity 
For quantifying the apoptosis induction by ORF3 in PK-15 cells after viral 
infection, a colorimetric assay specific for active caspase 3 was performed 
(caspACE assay system, PROMEGA) by following the manufacturer's 
instructions. Briefly, the cells were harvested at different time points after virus 
infection using a sterile cell scraper, washed in PBS, and resuspended in the 
supplied cell lysis buffer. The lysate was used for the colorimetric assay, which 
measured the cleavage of Ac-DVED-pNA substrate by active caspase 3. The 
caspase 3 activity in virus-infected cells was normalized to that of uninfected PK-
15 cells. 
4.2.6 Mice infections studies 
The experimental design consisted of four groups of 8-week-old BALB/c 
mice with sixteen mice per group. Each group of mice was housed in an 
individual room and handled separately. The mice were each inoculated, both 
intranasally and intraperitoneally, with 105 50% tissue culture infective doses of 
the PCV2. The zVADfmk (BD biosciences) was dissolved in DMSO vehicle to a 
final DMSO concentration of 20%. The zVAD was administered intra peritoneally 
at the rate of 1 mg/dose, once in 3 days, starting a day before the inoculation of 
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the virus and was continued up to 25 days post inoculation. The regimen was 
adapted from a previous study on Lymphocytic chorio meningitis virus (LCMV) 
infection in BALB/c mice model, which showed that the zVAD does not affect the 
course of the immune response against viral infection (Nussbaum and Whitton, 
2004). Four mice from each group were sacrificed at 1-week intervals and 0.5 ml 
of peripheral blood was collected from each mouse, for the estimation of viremia. 
The viral genomic DNA was isolated using QIAamp Blood DNA kit as mentioned 
above and quantified by real-time PCR. The spleen was dissected out for the 
isolation of the macrophage lineage cells. To describe the procedure briefly, the 
spleen cells were crushed out of the capsule and collected into heparinized PBS 
and the RBC were lysed using a commercial kit (UTI Lyse kit, Dako) and the 
macrophages were subsequently isolated with micro beads conjugated to mouse 
antiCD11b antibodies using magnetic cell sorting kit (MACS, Miltenyi biotec) by 
following the manufacturer's instructions. Flow cytometric analysis showed that 
more than 95% of the purified cells were CD 11b-positive. The purified cells were 
used to isolate the total RNA using Trizol Reagent (Invitrogen) following the 
manufacturer's instructions. The isolated RNA was treated with RNAse free 
DNAseI to remove any contaminated DNA. The levels of PCV2 Replicase RNA 
were estimated from the reverse transcribed RNA by real-time PCR using the 
following primers Rep forward 5′-GCGGCAGCACCTCG-3′ and Rep reverse 
GTC 5′-CTTCCTCATTACCCTCC-3′. The TNFα and GAPDH mRNA levels in 
the RNA fraction, after being reverse transcribed, were estimated by real-time 
PCR assay with the following primers; TNFα forward primer 5′-
TGATCCGCGACGTGGAA-3′, TNFα reverse primer 5′-
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ACCGCCTGGAGTTCTGGAA-3′, GAPDH forward primer 5′-

























4.3.1 Growth kinetics of wild-type PCV2 and ORF3-deficient PCV2.  
Our earlier experiments, in vitro in PK-15 cells and in vivo in mice and 
piglets, have shown that the growth kinetics of ORF3-deficient mutant PCV2 
always lagged behind that of the wild-type PCV2 (Liu et al., 2005, 2006; 
Karuppannan et al., 2009). In order to examine the pattern of virus spread in the 
PK-15 cell culture, the kinetics of the replication of the wild-type PCV2 virus and 
the ORF3 mutant PCV2 virus in PK-15 cells were measured by quantifying the 
viral genome copy numbers using quantitative real-time PCR assay. Parallel 
cultures of PK15 cells in 35-mm cell culture dishes were infected with PCV2 or 

















Figure 23. The wild-type PCV2 is released into the cell culture supernatant earlier 
than the ORF3-deficient mutant PCV2.The copy number of the viral genome after 
infection with wildtype PCV2 or mutant PCV2 at 18, 24, 36, 48, 72, and 96 h after 
infection were quantitated by real-time PCR. The viral genome copy numbers in 
the total cell culture or in the cell associated fraction and the cell free fraction 





















The virus genome copy numbers in the infected cultures from the cell free 
supernatant, attached cells and the total virus copy numbers in the supernatant 
along with the cells were separately quantified, at 18, 24, 36, 48, 72, and 96 h after 
infection. The results showed that the cell free virus numbers in the wild-type 
PCV2-infected cells were higher than in the ORF3 mutant PCV2-infected cultures 
(Fig. 23). This difference was higher in the early time points after infection 
compared with the later time points after infection. However, the cell associated 
virus levels of the wild-type and ORF3 mutant PCV2 at early time points were 
similar. The difference in the cell associated virus levels between the two viruses 
increased after 36 h post infection until they reached almost similar levels at 72 h 
post infection. These results clearly show that the higher replication kinetics of 














4.3.2 Role of ORF3-induced apoptosis in the spread of the virus in cell culture 
Many viruses are known to affect the apoptotic machinery of their host 
cells in the course of enhancing their evolutionary fitness (Devireddy and Jones, 
1999; Dey et al., 2002; Dobner et al., 1996; Granja et al., 2004; Jeurissen et al., 
1992; Noteborn et al., 1994; Roulston et al., 1999). The ORF3 of the PCV2 
induces apoptosis in the infected cells (Liu et al., 2005). To examine the possible 
role of the apoptotic function of ORF3 in the spread of virus, the PCV2 replication 
kinetics were assayed in the presence of 50 µMof zVAD, a pan-caspase inhibitor, 
which is known to block the p53 mediated apoptosis. The apoptotic induction by 
ORF3, measured by quantifying the caspase 3 activity with a colorimetric assay, 
was inhibited by the zVAD and the caspase 3 activity was similar in the ORF3 
















Figure 24. A, Expression levels of ORF3 in wild-type PCV2 and ORF3mutant 
PCV2 virus-infected PK-15 cells were assayed by Western blot. pcDNA3.1 ORF3 
expression plasmid transfected PK-15 cells were used as a control. B, Caspase 3 
activity induced by PCV2 is abolished by zVAD, a pan-caspase inhibitor. The 
ratio of caspase 3 activity in PK-15 cells at 18, 24, 36, 48, 72, and 96 h after 
infection with wild-type PCV2, mutant PCV2, wild-type PCV2 in the presence of 
50 µM zVAD and uninfected control, was measured using a colorimetric assay 










Figure 25. The release of PCV2 virus from the infected cells to the cell culture 
supernatant is inhibited in the presence of caspase inhibitor zVAD. The copy 
number of the viral genome after infection with wild-type PCV2 or mutant PCV2 
in the presence or absence of zVAD was quantitated by real-time PCR at 18, 24, 
36, 48, 72, and 96 h after infection. The viral genome copy numbers in the total 











The replication kinetics of the wild-type PCV2 and the ORF3-deficient 
PCV2 were quantified in the presence of the inhibitor (Fig. 25). The results 
showed that the cell free virus levels and total virus replication kinetics in the 
wild-type PCV2-infected cells were reduced in the presence of the inhibitor. 
However, the ORF3 mutant PCV2 did not show any change in its original 
replication kinetics in the presence of the inhibitor and especially, the cell free 
virus levels of the ORF3 mutant PCV2 were also not affected by the inhibitor. 
Further, in the presence of the inhibitor the replication kinetics of the wild-type 
PCV2 was similar to that of the ORF3 mutant PCV2 indicating that the apoptotic 
activity of the ORF3 contributes to the enhanced spread of the wild-type PCV2 to 
the supernatant.  
4.3.3 Mixed culture of ORF3-deficient PCV2 with a chimeric PCV1-2 virus 
 PCV1 is a non-pathogenic contaminant of the PK15 cell line and has been well 
documented to be a persistent non lytic infection even in other cell lines 
(Stevenson et al., 1999; Victoria et al., 2010). The ORF3 of the PCV1 
significantly varies from the ORF3 of PCV2 and does not cause apoptosis when 
expressed in cells (our unpublished observations). A chimeric PCV1-2 viral 
genome with the ORF2, origin of replication of the PCV1 and the ORF1, ORF3 of 
PCV2 was constructed and the virus was regenerated from the synthetic genome. 
In the context of above findings, an assay was performed to examine if in mixed 
infection of the ORF3-deficient PCV2 and the PCV1-2 chimeric virus, the ORF3 
of PCV2 expressed from the PCV1-2 chimeric virus can enable an early spread of 
the ORF3 mutant PCV2 virus to the cell free supernatant. The ORF3-deficient 
PCV2 was quantified by using primers specific for PCV2 ORF2 by a quantitative 
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PCR assay. The replication kinetics of the ORF3 mutant PCV2 in mixed culture 
with the chimeric PCV1-2 expressing the PCV2 ORF3 was higher compared to 
the pure ORF3 mutant PCV2 infection (Fig. 26). The mixed culture with the 
PCV1-2 chimera displayed an early increase in the cell free virus levels of the 
ORF3-deficient PCV2 compared to the pure culture of ORF3-deficient PCV2, and 
this increase was reversed in the presence of 50 µM of zVAD in mixed virus 
infection cultures, showing that the apoptosis induced by the ORF3 is necessary 
for this spread of the virus into the cell free supernatant. This again directly shows 



















Figure 26. The release of mutant PCV2 from the infected cells is enhanced by 
complementation of the ORF3 expression. The copy number of the viral genome 
after infection with mutant PCV2 or mutant PCV2 in the presence of chimeric 
PCV1 expressing the ORF3 of PCV2, were quantitated by real-time PCR at 18, 
24, 36, 48, 72 and 96 h after infection. The viral genome copy numbers in the total 





















4.3.4 Role of ORF3-induced apoptosis in the in vivo spread of the virus 
We next wanted to examine if the ORF3-induced apoptosis plays a role in 
the spread of the virus in an in vivo infection. Many reports have shown that in 
vivo administration of zVAD in mice blocks p53 induced apoptosis (Emamaullee 
et al., 2007; Nussbaum and Whitton, 2004; Sarkar et al., 2006). To study the role 
of ORF3-induced apoptosis in PCV2 virus spread, four groups of BALB/c mice 
were inoculated with 105 TCID50 of wild-type PCV2 or ORF3-deficient PCV2 
virus in the presence or absence of zVAD. The zVAD regimen used here has been 
previously shown not to adversely affect the health of the mice or affect the 
immune response of mice to viral infection (Nussbaum and Whitton, 2004). The 
systemic spread of the wild-type PCV2 virus, assayed by serum viremia, was 
reduced in the presence of the zVAD (Fig. 27). On day 7 post infection the serum 
viremia could not be detected in the group infected with wild-type virus in the 
presence of zVAD and at all subsequent time points, the viremia in this group was 
less compared to the group infected with wild-type PCV2 in the absence of 
zVAD. However, the kinetics of systemic virus spread of the groups infected with 
ORF3-deficient PCV2 virus was not altered by the presence of the inhibitor 
zVAD. These observations show that the apoptosis induced by ORF3 plays a role 









Figure 27. The apoptosis induced by ORF3 of PCV2 enhances the spread of the 
virus in vivo. The serum viremia of mice infected with wild-type PCV2 or mutant 
PCV2 in the presence or absence of zVAD was quantified using real-time PCR 














4.3.5 Role of macrophages in the spread of PCV2 viremia 
Phagocytic cells play a central role in the clearance of apoptotic cells (Erwig and 
Henson, 2008). The apoptosis induced by PCV2 ORF3 in infected cells could 
facilitate the macrophage mediated systemic spread of the virus. Indeed, in the 
analysis of natural PCV2 infections in piglets, with severe disease manifestation, 
macrophages have been found to contain a high load of PCV2 virus and this has 
also been correlated with a high level of systemic PCV2 viremia (Darwich et al., 
2004; Harding et al., 2008; Krakowka et al., 2002; Sanchez et al., 2004; Stevenson 
et al., 2001; Wallgren et al., 2009). This phenomenon could also be observed in 
mice models of PCV2 infection, where macrophages were found to contain PCV2 
antigen (Kiupel et al., 2001). When we examined the virus levels in macrophages 
in the infected mice, the wild-type PCV2-infected mice displayed a higher level of 
virus in the macrophages compared to ORF3-deficient PCV2-infected mice (Fig. 
28). However, in the presence of zVAD, the wild-type PCV2-infected mice 
showed lower virus levels in the macrophages, comparable to the levels in mice 
infected with ORF3-deficient PCV2 virus. The ORF3-deficient virus-infected 
mice on the other hand did not show any alteration in the virus levels in 
macrophages in the presence of zVAD. These results show that the apoptosis 
induced by ORF3 of PCV2 helps in enhancing the systemic spread of the virus by 
increasing the uptake of the virus by macrophages. The ability of macrophages to 
support the replication of PCV2 is a debated issue (Yu et al., 2007; Perez-Martin 
et al., 2007; Sanchez et al., 2004; Darwich et al., 2004; Vincent et al., 2003). We 
next examined if the macrophages could support the replication of the virus or 
merely serves to disseminate the virus. RNA was isolated from purified CD11b-
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positive splenic cells from the different groups of mice and were examined for the 
levels of PCV2 replicase mRNA. The results showed that PCV2 replicase (ORF1) 
RNA expression could not be detected in the CD11b-positive splenic cells in mice 
from any of the groups (data not shown). This shows that PCV2 does not replicate 
in the macrophage cells, at least in the mice model of infection. Further, previous 
studies have shown that TNFα levels are elevated in the PMWS affected pigs and 
could contribute to the progression of the disease (Sipos et al., 2005; Kim et al., 
2006; Shi et al., 2010). The in vitro infection of primary porcine alveolar 
macrophages with PCV2 also leads to an elevation of TNFα secretion (Chang et 
al., 2006). Supporting this observation, intramuscular injection of the ORF3 
expression plasmid in mice has been shown to cause mortality and a significant 
elevation in the TNFα levels (An et al., 2008). We examined the levels of TNFα 
mRNA in the macrophages of mice in the different groups. The wild-type PCV2-
infected mice showed an elevated TNFα mRNA level, relative to the mice 
infected with wild-type virus in the presence of zVAD (Fig. 29). Mice infected 
with the ORF3 mutant PCV2, in the presence or absence of zVAD, showed 
significantly lower levels of TNFα mRNA in the macrophages compared to the 
wild-type PCV2-infected mice. This indicates that ORF3-induced apoptosis and 
macrophage recruitment lead to elevated TNFα levels, which has been linked with 








Figure 28. The apoptosis induced by ORF3 of PCV2 enhances the viral load in 
macrophages in infected mice. The virus load in macrophages of mice infected 
with wild-type PCV2 or mutant PCV2 in the presence or absence of zVAD was 
quantified using real-time PCR assay at 7, 14, 21, and 28 days after infection 





























Figure 29. ORF3 of PCV2 contributes to elevated TNFα expression in 
macrophages of infected mice. The relative expression level of TNFα mRNA in 
macrophages of mice infected with wild-type PCV2 or mutant PCV2 in the 
presence or absence of zVAD was quantified using real-time PCR assay at 7, 14, 
















Porcine circovirus 2 is the principal infectious agent implicated in the 
development of PMWS and other PCVADs (Allan et al., 1998; Ellis et al., 1998). 
The virus associated factors that are implicated in the spread and pathogenesis of 
the virus are the polymorphisms in the capsid of the virus and the apoptosis 
induced by the ORF3 protein in the virus-infected cells (Cheung et al., 2007; 
Timmusk et al., 2008; Finsterbusch and Mankertz, 2009; Shibahara et al., 2000; 
Liu et al., 2005, 2006; Timmusk et al., 2008; Karuppannan et al., 2009). Viruses 
are genomic parasites that evolve to usurp cellular proteins and pathways for their 
benefit. Some viruses inhibit apoptosis in the host cells, while others induce 
apoptosis (Devireddy and Jones, 1999; Dey et al., 2002; Dobner et al., 
1996;Granja et al., 2004; Jeurissen et al., 1992;Noteborn et al., 1994; Everett and 
McFadden, 1999). The PCV2 ORF3 protein induces apoptosis in the infected cells 
in a p53-dependent manner (Liu et al., 2005). The ORF3 protein interacts with 
Pirh2, an E3 ligase specific for p53. This interaction leads to the sequestration of 
Pirh2 in the cytoplasm and a decrease in its half-life, leading to the increased 
cellular levels of p53 and apoptosis (Liu et al., 2007; Karuppannan et al., 2010). 
Our previous studies of ORF3-deficient PCV2 infection in mice and SPF piglets 
showed an absence of lymphoid organ depletion and reduction in lymphocyte 
counts in the course of the viral infection, usually found in infections with wild-
type PCV2 (Karuppannan et al., 2009). Further, these studies showed delayed 
kinetics of systemic viremia in infections with the ORF3-deficient PCV2 virus 
along with the reduction in the level of peak systemic viremia compared to the 
wild-type PCV2 infection. However, the ORF3 of PCV2 is not essential for the 
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replication of the virus both in vitro and in vivo (Liu et al., 2005, 2006). These 
observations indicate that the apoptosis induced by the ORF3 of PCV2 may play a 
role in enhancing the systemic spread of the virus without directly affecting the 
replication of the virus. Here, we have examined the role of ORF3-induced 
apoptosis in the spread of the virus using in vitro and in vivo experiments. 
Our in vitro experiments reported here show that the apoptosis induced by 
the ORF3 of PCV2 enables the earlier release of the wild-type PCV2 virus to the 
cell free supernatant compared to the ORF3-deficient PCV2 virus (Figs. 23, 24). 
The released virus re-infects other cells, and this amplification cycle results in the 
observed enhancement in the replication kinetics. The pan-caspase inhibitor 
zVAD inhibits the apoptosis induced by the ORF3 protein and delays the release 
of the wild-type PCV2 virus into to the cell free supernatant, leading to a delayed 
virus replication kinetics (Figs. 24, 25). This is similar to the virus release pattern 
and replication kinetics of the mutant PCV2 deficient in ORF3 expression. On the 
same note, the PCV1, which does not induce apoptosis in the infected cells, is 
known as a persistent, un-evident virus infection in cell lines of porcine origin 
(Stevenson et al., 1999), and recently contamination of PCV1 has been observed 
even in cell lines used for production of live attenuated vaccines for human use 
(Victoria et al., 2010). Ultra-structural studies of PK-15 cells persistently infected 
with PCV1 shows that the assembled virus accumulates as dense para-crystalline 
arrays in the cytoplasm of the infected cells (Stevenson et al., 1999). Our 
experiments here show that in the absence of the ORF3, the mutant PCV2 also 
accumulates in the cytoplasm of the infected cells, possibly until the replication of 
the virus overwhelms the cellular homeostasis resulting in the release of the virus. 
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In mixed infections with ORF3-deficient PCV2 and the PCV1-2 chimeric virus 
expressing the PCV2 ORF3, the replication kinetics of ORF3-deficient PCV2 is 
increased aided by the early release of cell free virus, and this increase is reversed 
by the presence of zVAD (Fig. 26). Thus, the ORF3-induced apoptosis of PCV2-
infected cells enhances the release of the virus and enables its spread.  
Mice infected with wild-type PCV2 reveals a faster in vivo spread 
compared to infection with ORF3-deficient PCV2, as measured by the serum 
viremia (Fig. 27). The higher rate of virus spread of the wild-type PCV2 in mice is 
reduced by the co-administration of zVAD, a pan-caspase inhibitor that is known 
to block p53 induced apoptosis. This shows that apoptosis induced by PCV2 
ORF3 facilitates the in vivo spread of the virus. Supporting this view, prior 
infection studies in mice and SPF piglets display lower virus replication kinetics 
of ORF3-deficient PCV2 compared with the wild-type PCV2 (Liu et al., 2006; 
Karuppannan et al., 2009). Further in cases of natural infections of PCV2 in 
piglets with high levels of serum viremia that develop to PMWS, macrophages are 
found to contain a high viral antigen load (Darwich et al., 2004; Harding et al., 
2008; Krakowka et al., 2002; Sanchez et al., 2004; Stevenson et al., 
2001;Wallgren et al., 2009). This was also observed in mice experimentally 
infected with PCV2, which display a high viral load in macrophages (Kiupel et al., 
2001). However, whether the PCV2 actively replicates in the macrophages is a 
debated issue, as some reports show the absence of the replicative form of the 
viral genome and absence of nuclear antigenic signal in these cells (Perez-Martin 
et al., 2007; Darwich et al., 2004; Vincent et al., 2003). Macrophages along with 
other phagocytic cells bring about the clearance of apoptotic cells (Erwig and 
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Henson, 2008) and could inadvertently expedite the systemic dissemination of the 
PCV2 virus by engulfing virus-infected apoptotic bodies and transporting them to 
the regional lymph nodes, which are thought to be initial sites for PCV2 
replication in natural infection (Yu et al., 2007; Vincent et al., 2003). In our 
observations, mice infected with wild-type PCV2 have a higher viral load in the 
macrophages compared to mice infected with the ORF3-deficient PCV2 or the 
wild-type PCV2-infected mice treated with zVAD (Fig. 28). This again shows a 
direct relationship between the PCV2 induced apoptosis and the spread of the 
virus through the macrophages. Further, the cytokine secretion by macrophages is 
known to be influenced by the presence of apoptotic cells (Lucas et al., 2003). Our 
observations here show that the macrophages in wild-type PCV2-infected mice 
have an elevated level of TNFα (Fig. 29), which is typically observed in PCV2-
infected piglets with PMWS (Sipos et al., 2005; Kim et al., 2006, Shi et al., 2010). 
This elevation of TNFα is not observed in macrophages of mice infected with 
ORF3-deficient PCV2. The ORF3 mediated elevation of TNFα was also observed 
in other studies, when plasmid expression vector encoding ORF3 was injected into 
mice, leading to severe symptoms and death (An et al., 2008). The signaling 
mechanism involved in this cytokine induction needs to be further elucidated. In 
summary, the apoptosis induced by ORF3 of PCV2 hastens the exit of the virus 
from the infected cells, enables the macrophage mediated systemic spread of the 
virus, and also influences the cytokine secretion by the macrophages. 
The role of virus induced apoptosis in the lymphocyte depletion and the 
progression of PCV2 associated diseases has been reported in many studies 
(Shibahara et al., 2000; Nielsen et al., 2003; Liu et al., 2005, 2006; Timmusk et 
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al., 2008; Karuppannan et al., 2009). Our previous studies have shown that ORF3-
induced apoptosis leads to lymphocyte depletion in PCV2-infected mice and 
piglets (Liu et al., 2006; Karuppannan et al., 2009). However, the role of apoptosis 
in PCV2 pathogenesis has also been contested by other reports (Mandrioli et al., 
2004; Resendes et al., 2004). On the same note, a recent report of ORF3-deficient 
PCV2 infection in conventional PCV2 free piglets claims that apoptosis induced 
by ORF3 does not play a significant role in the pathogenicity of the virus; 
however, on the contrary, their data shows reduced viral replication kinetics and 
lower peak viremia level in the ORF3-deficient PCV2-infected piglets compared 
to wild-type PCV2-infected piglets, supporting our findings (Juhan et al., 2010). 
Our observations here directly show that the ORF3 mediated apoptosis expedites 
the exit of the virus from the infected cells, which otherwise could be accumulated 
in the infected cells. The apoptosis mediated by ORF3 also leads to the rapid 
systemic dissemination of PCV2 infection by recruiting the macrophages, which 
could seed the draining lymph nodes with the virus, accelerating the progression 
of the viral spread. The ORF3, which is not directly involved in the replication of 
the virus, thus plays an important role in the systemic spread of the viral infection. 
The involvement of specific immune cells in the systemic pathogenesis of the 
PCV2 could be further explored in “knockout mice” lacking specific components 
of the immune system. Further studies to examine the role of ORF3 in the spread 
of PCV2 virus from one piglet to another are necessary, as the ORF3 may also 
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5.1 The role of ORF3 in the pathogenicity of PCV2 infection and the 
molecular mechanism behind the cellular pathogenesis  
The Porcine circovirus 2 has emerged as one of the most harmful 
pathogens in the porcine species since it was discovered to be associated with 
PMWS in 1997 (Clark et al., 1996, Ellis J et al., 1998, Hamel et al., 1998, 
Harding, J. C., 2004, Nayar et al., 1997). Interestingly, PCV2 is the smallest 
animal virus based on its genome size (~1.7kb) and virion size (17nm diameter), 
and utilizes host cellular factors for the replication of its single stranded circular 
genome and morphogenesis (Finsterbusch et al., 2009). Research on the Porcine 
circoviruses in the past decade has unraveled many features of the biology of the 
virus including its entry mechanisms, replication mechanism, structural studies of 
the viral proteins, epidemiology and pathology of the viral infection, etc 
(Finsterbusch et al., 2009, Ramamoorthy et al., 2009, Grau-Roma et al., 2011). 
The pathogenesis during the PCV2 infection, as with any infectious agent, is 
depended on virus associated factors, host factors and environmental/husbandry 
associated factors. The PCV2 virus is ubiquitous in its distribution and the 
PCVADs ravage pig production facilities throughout the world. However, 
differences are found among the various farmed pig breeds such as Pietrain, 
Duroc, Large white in their susceptibility to PCV2 infection and even individuals 
within a breed differ in their response to the PCV2 infection (Stevenson et al., 
2007, Lopez-Soria et al., 2004, 2011). This reflects the significant role of host 
genetic factors in the response to PCV2 infection. The virus associated factors that 
are implicated in pathogenesis should be theoretically linked with the 
polymorphisms in the three genes coded by the PCV2 (ORF1, ORF2 and ORF3), 
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the regulatory regions of these three ORFs, or other epigenetic and non genetic 
factors associated with the viral genome.  
The single stranded circular viral genome of PCV2 is known to have 
immuno-modulatory properties such as modulation of Interferon α or TNF α 
production by porcine peripheral blood monocytes and plasmacytoid Dendritic 
cells (Kekarainen et al., 2008, Vincent et al., 2005, 2007, Wikstrom et al, 2007, 
2011). The PCV2 genome contains secondary structures such as hairpins, double 
strands, CpG motifs and variations in the methylation status of their CpG motifs, 
all of which affect the cytokine induction in response to PCV2 infection (Vincent 
et al., 2005, 2007, Wikstrom et al, 2007, 2011).  
Knowledge on the regulatory non-coding RNAs has exploded in the past 
few years and miRNAs encoded by viruses are well known (Grundhoff et al., 
2011, Ichimura et al., 2011, Sato et al., 2011). Viruses are also known to perturb 
cellular miRNA and RNAi pathways (Haasnoot et al., 2011). It is reasonable to 
examine if the PCV2 genome, which replicates in the nucleus, codes for any 
miRNA. Infact, the intron of the ORF1 has a predicted stem-loop structure which 
could potentially serve as a precursor for miRNA (our unpublished analysis). 
However, our experimental observations and reports from elsewhere, based on 
deep sequencing, indicate that the PCV2 genome does not code for any miRNAs 
(Núñez. F et al., Centre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, 
Spain; 2011, Proceedings of 6th International Symposium on Emerging and Re-
emerging Pig Diseases).  
When the viral genes per se are analyzed, the ORF1 is highly conserved 
and does not have any reported polymorphisms. Capsid protein, on the other hand, 
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has many polymorphisms which are associated with the cell culture adaptation of 
the virus and other naturally occurring variations in viruses circulating in swine 
populations (Cheung et al., 2007; Cortey et al., 2010; Fenaux et al., 2004,  Gagnon 
et al., 2007; Wiederkehr et al., 2009). The widely accepted geno-groups in PCV2, 
based on the natural variations in the capsid protein, are the PCV2a and PCV2b 
strains. Interestingly, the recent years have seen the increase in the incidence of 
the PCV2b strains across the globe (Cortey et al., 2011). The basis behind this 
expansion of PCV2b strains is not completely understood. Experimental infections 
in gnotobiotic pigs to find if there are any differences between the pathogenicity 
of ORF2a and ORF2b have shown that both viruses are indeed similar in their 
pathogenicity (Gauger et al., 2011). A recently published experimental analysis of 
PCV2a and PCV2b, shows that specific amino acid motifs in the PCV2 capsid 
protein might be associated with increased replication fitness of the virus (Cheung 
et al., 2011). These indicate that ORF2 might not be directly related to 
pathogenesis. The work described in this thesis shows the pathogenic role of 
apoptosis induced by ORF3 during PCV2 infection at the cellular level and in the 
natural host species (using SPF piglet model) (Karuppannan et al., 2010, 2011). A 
recently published report showing apoptotic cells in various parenchymatous 
organs reiterates the role of the apoptosis in the pathology of PCV2 infection 
(Resendes et al., 2011).  The work reported in this thesis has led us to the 
following conclusions. 
5.1.1 Conclusion 1 
The findings of this work show in detail that the virus induced apoptosis in 
the infected piglets causes the lymphocyte depletion and the lymphoid organ 
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destruction. The ORF3 deficient PCV2 virus is markedly attenuated and its 
infection is characterized by reduced viremia, absence of lymphocyte depletion 
and histological lesions in lymphnodes and other parenchymatous organs of the 
host.   
5.1.2 Conclusion 2 
Our experiments have revealed the molecular mechanism by which the 
ORF3 causes cellular pathogenesis. The ORF3 of PCV2 binds pPirh2, disrupts its 
normal subcellular localization, decreases the stability of Pirh2 and prevents its 
physiological interaction with p53 (Karuppannan et al., 2010). These events lead 
to the increase in the p53 levels, leading to the induction of apoptosis of virus 
infected cells.  
5.1.3 Conclusion 3 
Our experimental observations show that the ORF3 induced apoptosis also 
expedites the systemic spread of PCV2 infection in piglets (Karuppannan et al., 
2009). Further experiements using the PK-15 cells and mice model show that 
ORF3 induced apoptosis enables the egress of the PCV2 from infected cells both 
in vitro and in vivo (Karuppannan et al., 2011). A recently published report on the 
ultra-structural morphogenesis of PCV2 provides further evidence for host cell 
apoptosis in enabling the release of the virus accumulated inside the cells 
(Rodríguez-Cariño et al., 2011). Our experiments in mice also indicate that 
systemic dissemination of the virus is enabled by the uptake of virus infected 
apoptotic cells by phagocytic cells of the immune system. It would be interesting 
to study the facilitating role of ORF3 induced apoptosis in the systemic 
dissemination of the virus by phagocytic cells in piglets, as these are the natural 
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hosts. Specific phagocytic cell populations in piglets can be selectively ablated by 
chemical reagents, such as liposome-encapsulated clodronate to deplete 
macrophages or cyclophosphamide to deplete Neutrophils in order to study the 
role of these cells in clearing PCV2 induced apoptotic bodies and systemically 
disseminating the virus (Cote et al., 2006, Shifrin et al., 2005). A comparison of 
the pattern of systemic spread of PCV2, ORF3 deficient PCV2 and PCV1 in 
piglets, with the administration of the above chemical agents, would enable a 
better understanding of the contribution of the ORF3 induced apoptosis to viral 
dissemination at the organismal level.  
Analysis of the literature on the PCV2 also provides supporting evidence 
for the role of ORF3 in the PCV2 pathogenesis. A molecular epidemiological 
study by Timmusk et al., (2008) of the temporal and spatial distribution of 
archived virus genetic sequences in Sweden reveals that phylogenetic grouping 
based on ORF3 sequences correlate with the temporal emergence and incidence of 
PMWS in distinct geographical locations. This shows that polymorphisms in the 
ORF3 are correlated with the pathogenicity. Another recent analysis of 
evolutionary patterns in the Porcine circoviruses indicates that the ORF3 of PCV2 
could be under positive selection (Firth et al., 2009). These molecular 
epidemiological observations reiterate the experimental observations presented in 
this thesis. In summary, the work described in this thesis, along with analysis of 
evidence from published literature, show that PCV2 ORF3 is one of the most 




5.2 Future directions  
The ORF3 deficient PCV2 is a potential candidate for development of a 
live attenuated vaccine (Karuppannan et al., 2009). Currently, many inactivated 
and subunit vaccines are commercially available to control PCV2 infection, 
however a live attenuated vaccine would stimulate the cell mediated immune 
response better than the inactivated or subunit vaccines (Kekarainen et al., 2010). 
The ORF3 deficient PCV2 has an advantage in this regard as it is not pathogenic 
and can prime the humoral and cell mediated immune response. Further studies to 
characterize the T cell response induced by the mutant virus after experimental 
inoculation, shedding pattern of the mutant virus, genetic stability of the mutant 
virus in serial passages in piglets, and challenge after vaccination with the mutant 
virus will help in the development of ORF3 deficient PCV2 as a modified live 
vaccine. 
 On another aspect, the specific interaction of ORF3 with the Pirh2, an 
important suppressor of p53 levels, could be put to beneficial use (Karuppannan et 
al., 2010).  The cellular Pirh2 levels could be brought down by administration of 
ORF3 to tumor cells and thereby indirectly elevating pro-apoptotic p53 levels to 
induce apoptosis.  Utilization of virus or viral proteins for tumor therapy has been 
explored in many instances (Argiris et al., 2011, Pavet et al., 2011). The possible 
antitumor effects of ORF3 could be initially explored in human cancers of lungs, 
prostate, neck, etc., which present an over expression of Pirh2 (Duan et al., 2004, 
Logan et al., 2006, Shimada et al., 2009, Wang et al., 2009). The ORF3 can also 
be cloned into an appropriate viral vector for gene delivery in tumor therapy. 
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The ORF3 induced apoptosis explains the major features in the pathology 
associated with the PCV2 infection, namely the destruction of lymphoid organs, 
decrease in lymphocyte count, immunosuppression, etc. However, other features 
of PCV2 associated pathology, like altered cytokine profile (Doster et al., 2010,  
Darwich et al., 2003, Stevenson et al., 2006) and manifestations of autoimmune 
like inflammation (Resendes et al., 2011) should be examined. In particular, one 
study has revealed that PCV2, but not PCV1, can induce the secretion of IL-10 in 
in vitro PBMC cultures (Kekarainen et al., 2008 a, b, Stevenson et al., 2006). As 
mentioned earlier the structural and CpG motifs in the PCV2 genome modulate 
the Type I interferon secretion. However, there is lack of understanding of how 
PCV2 causes the elevated levels of other systemic cytokines such as IL-10, TNFα 
found in conditions of PCVAD (An et al., 2008, Darwich et al., 2003, Stevenson 
et al., 2006). Our observation and studies by others have indicated that the ORF3 
has the potential to modulate systemic cytokine levels (An et al., 2008, 
Karuppannan., 2011). The basis behind the ability of the ORF3 to alter the 
systemic cytokine profile in pigs infected with PCV2 needs to be studied. Further, 
a recently discovered subset of T lymphocytes which antagonize the regulatory T 
cells, the Th-17 lymphocytes and the associated cytokines are shown to play an 
important role in the inflammatory lesions associated with virus infections (Elhed 
et al., 2010, Littman et al., 2010). It would be interesting to examine the role of 
such Th-17 cell populations in the PCV2 infections, as its pathology is 
characterized by excessive inflammation. Notwithstanding these aspects of the 
PCV2 pathogenesis which are yet to be studied, the ORF3 is a pivotal virus 
associated factor influencing the pathogenesis of PCV2 in the porcine species. 
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